# Chapter 28: Major Depressive Disorder

## The Biological and Neurological Basis of Major Depressive Disorder

### Introduction

Major Depressive Disorder (MDD) is a globally prevalent and debilitating psychiatric condition characterized by a persistent and pervasive low mood, a loss of interest or pleasure in activities (anhedonia), and a constellation of emotional, cognitive, and somatic symptoms that cause significant impairment in daily functioning (Bains et al., 2021; Luthra, 2017; Sheets & Brosse, 2010). To meet the diagnostic criteria for MDD, an individual must experience at least five of a specific set of symptoms, including one of the two core features of depressed mood or anhedonia, for a period of at least two weeks (Bains et al., 2021; Sheets & Brosse, 2010; Falk et al., 2023). These associated symptoms can include significant changes in appetite or weight, disturbances in sleep patterns such as insomnia or hypersomnia, psychomotor agitation or retardation, profound fatigue or loss of energy, feelings of worthlessness or excessive guilt, diminished ability to think or concentrate, and recurrent thoughts of death or suicide (Bains et al., 2021; Sheets & Brosse, 2010; Falk et al., 2023; Kennedy, 2008).

While the lived experience of depression is profoundly psychological, decades of research have firmly established that MDD is a serious medical illness involving the brain (Kotade et al., 2011; Rodrigues, 2022). It is not merely a reaction to life's disappointments or a variation of normal sadness (Kotade et al., 2011; Torpy, 2006). Instead, MDD is understood to arise from a complex interplay of social, psychological, and biological factors (Quintana Coronado et al., 2017; Filipenka, 2021). This chapter focuses on the latter, providing a comprehensive overview of the biological and neurological mechanisms currently understood to underlie the pathophysiology of MDD.

The biological underpinnings of depression are multifaceted, involving dysregulation across several key systems. These include alterations in neurotransmitter systems, structural and functional changes in specific brain regions and neural circuits, genetic predispositions, and disruptions in the body's stress response and circadian rhythms (Hadi et al., 2017; Kotade et al., 2011). Evidence for these biological bases comes from a wide range of scientific inquiry, including the mechanisms of action of effective antidepressant medications, neuroimaging studies that reveal changes in brain activity and structure, and genetic studies that point to the heritability of the disorder (Dodd, 2007; Kanner & Dunn, 2004). Understanding these biological foundations is not only crucial for refining diagnostic approaches and reducing the stigma associated with mental illness (Rodrigues, 2022) but also for developing more targeted and effective therapeutic interventions. This chapter will synthesize the evidence for these mechanisms, exploring the intricate neurobiology of this complex disorder.

### Neurobiological Systems

The investigation into the biological basis of Major Depressive Disorder has implicated a range of interconnected systems, from the molecular level of neurotransmitters to the complex regulation of the body's stress and sleep-wake cycles. While no single mechanism can fully account for the heterogeneity of MDD, a confluence of evidence points toward significant dysregulation in several key areas.

#### Neurotransmitter Systems and Neuropharmacology

The monoamine hypothesis has been a dominant framework for understanding the neurochemistry of depression for decades (Trivedi et al., 2020). This hypothesis posits that the core symptoms of depression are caused by a functional deficiency of brain monoaminergic transmitters, specifically norepinephrine (NE), serotonin (5-HT), and/or dopamine (DA) (Nayudu Teja et al., 2020; Fiar et al., 2012). Much of the evidence supporting this hypothesis is derived from the mechanisms of action of antidepressant medications (Kotade et al., 2011).

Selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine, sertraline, and paroxetine, are widely considered first-line treatments for MDD due to their favorable safety and tolerability profiles (Akram et al., 2023; Trivedi et al., 2020; Gordon & Leder, 2012). These agents are believed to exert their therapeutic effects by blocking the presynaptic reuptake of serotonin, thereby increasing its availability in the synaptic cleft (Rosenbaum & Zajecka, 1997; Gordon, 2014). Similarly, serotonin-norepinephrine reuptake inhibitors (SNRIs), like venlafaxine and duloxetine, increase the levels of both serotonin and norepinephrine (Akram et al., 2023; Trivedi et al., 2020). The efficacy of these drugs provides strong, albeit indirect, evidence for the involvement of serotonergic and noradrenergic systems in the pathophysiology of depression (Fiar et al., 2012; Hsieh et al., 2010). The older tricyclic antidepressants (TCAs), such as amitriptyline, also affect these systems, though with a broader and less selective range of action and a greater burden of side effects (Akram et al., 2023; Edwards, 1995; Hindmarch, 1998). Discontinuation syndromes associated with the abrupt withdrawal of shorter half-life SRIs, which can include somatic symptoms like dizziness and fatigue as well as psychological symptoms like anxiety and irritability, further underscore the profound physiological adaptations that occur within these neurotransmitter systems during treatment (Rosenbaum & Zajecka, 1997; Kaplan, 1997).

The role of dopamine is also increasingly recognized, particularly in relation to symptoms of anhedonia (the loss of pleasure) and motivational deficits (avolition) (Modugno et al., 2013; Nayudu Teja et al., 2020). Evidence for dopaminergic dysfunction in depression comes from several lines of inquiry. Comorbid depression is common in Parkinson's disease, a condition defined by the degeneration of dopaminergic neurons (Bell, 2008; Modugno et al., 2013). Furthermore, drugs that stimulate dopamine release, such as amphetamines, can produce psychotic symptoms but also have mood-altering effects, while some atypical antipsychotics with dopaminergic activity are used in the management of depression (Dodd, 2007; Montes & Rey, 2009). The mesolimbic dopamine system, a key circuit involved in reward processing and motivation, is thought to be hypoactive in certain depressive states (Costentin, 2015; McNamara et al., 2002). This is consistent with the observation that individuals with depression exhibit a reduced response to rewarding stimuli (Maj, 2023).

Beyond the classic monoamines, other neurotransmitter systems are also implicated. The inhibitory neurotransmitter gamma-aminobutyric acid (GABA) is thought to be dysregulated, contributing to the high comorbidity between depression and anxiety disorders (Batinić et al., 2017; Sakakibara & Katsuragawa, 2022). Benzodiazepines, which enhance GABAergic function, are often used to manage acute anxiety and insomnia in depressed patients, though their long-term use is limited by risks of dependence (Bismuth et al., 1980; Ashton, 1994). The excitatory neurotransmitter glutamate has also become a focus of research, with dysfunction in this system potentially underlying some of the cognitive impairments seen in depression (Batinić et al., 2017). Ketamine, an antagonist of the NMDA glutamate receptor, has shown rapid antidepressant effects in treatment-resistant cases, suggesting that targeting the glutamatergic system may offer new therapeutic avenues (Ghaisani, 2018).

#### The Stress Response and the Hypothalamic-Pituitary-Adrenal (HPA) Axis

Stress is a well-established precipitating factor for depressive episodes (van Praag et al., 2004; Sandi, 2013). Exposure to adverse life events, such as loss, trauma, or chronic difficulties, frequently precedes the onset of MDD (Yadav, 2005; Quintana Coronado et al., 2017). The biological link between stress and depression is primarily mediated by the hypothalamic-pituitary-adrenal (HPA) axis, the body's central stress response system (van Praag et al., 2004; Chu et al., 2019). When an individual perceives a threat, the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the pituitary gland to release adrenocorticotropic hormone (ACTH). ACTH, in turn, signals the adrenal glands to produce glucocorticoids, such as cortisol (Stratakis et al., 1995; Pervanidou & Chrousos, 2011).

In many individuals with MDD, the HPA axis is hyperactive, resulting in elevated levels of cortisol (van Praag et al., 2004; Goodyer et al., 2000). This hyperactivity is thought to result from impaired negative feedback mechanisms, particularly involving glucocorticoid receptors in the hippocampus and hypothalamus, which normally act to shut down the stress response (van Praag et al., 2004). Chronic exposure to high levels of cortisol can have neurotoxic effects, particularly on the hippocampus, a brain region crucial for memory and mood regulation (Sandi, 2013; Ruiz-Rizzo & Lópera Restrepo, 2008). This can lead to a vicious cycle where stress-induced cortisol damages the very brain structures needed to regulate the stress response, further perpetuating HPA axis dysregulation (van Praag et al., 2004). Studies in high-risk adolescents have shown that higher morning cortisol levels, in conjunction with recent personal disappointments, can predict the onset of a major depressive episode (Goodyer et al., 2000). This suggests that HPA axis dysregulation may be a key component of the biological vulnerability to depression when interacting with environmental stressors (van Praag et al., 2004).

#### Circadian Rhythms and Sleep Disturbances

Disruptions to the body's internal biological clock, or circadian rhythms, are a hallmark of MDD (Wirz-Justice, 1986; Latta & Cauter, 2003). The clinical presentation of depression often includes a distinct diurnal variation in mood, with symptoms typically being worse in the morning (Halle et al., 1991; Manica et al., 1999). This temporal pattern is mirrored by dysregulation in the 24-hour rhythms of various physiological processes, including body temperature and hormone secretion, such as cortisol and melatonin (Wirz-Justice, 1986; Wetterberg, 1987).

Sleep disturbances are one of the most common and distressing symptoms of MDD, included in the core diagnostic criteria (Bains et al., 2021; Kennedy, 2008). These can manifest as insomnia (difficulty initiating or maintaining sleep) or, less commonly, hypersomnia (excessive sleep) (Sheets & Brosse, 2010; Falk et al., 2023). Insomnia is a particularly strong risk factor for the development of major depression (Schenck, 2003; Winkelman, 2009). Polysomnographic studies have identified characteristic changes in the sleep architecture of depressed individuals, including reduced REM sleep latency (the time from sleep onset to the first REM period), increased REM density (the frequency of rapid eye movements during REM sleep), and a reduction in slow-wave sleep (also known as deep sleep) (Howland, 2010; Novati, 2012; Dodd, 2007).

These disruptions in circadian and sleep-wake regulation are not merely symptoms but are thought to be fundamentally involved in the pathophysiology of the disorder (Wirz-Justice, 2003). The central pacemaker for circadian rhythms is located in the suprachiasmatic nuclei (SCN) of the hypothalamus, which receives direct input from the retina to synchronize internal rhythms with the external light-dark cycle (Arendt, 2000; Latta & Cauter, 2003). Dysfunctional signaling within this system and its downstream targets could contribute to the mood and sleep disturbances seen in depression (Wirz-Justice, 1986). Therapeutic interventions that target circadian rhythms, such as sleep deprivation (which can have a rapid but transient antidepressant effect) and light therapy, provide further evidence for the role of this system in MDD (Dessauer et al., 1985; Wirz-Justice, 2003).

### Genetic and Molecular Basis

Major Depressive Disorder is recognized as a complex condition arising from the interaction of genetic vulnerabilities and environmental factors (Gleason et al., 2022; Quintana Coronado et al., 2017). While no single gene causes depression, evidence from family, twin, and adoption studies consistently indicates that the disorder has a significant heritable component (Cadoret & Winokur, 1972; Dodd, 2007). Genetic factors are thought to establish a biological vulnerability, which, when combined with adverse life events or environmental stress, increases the risk of developing a depressive episode (Prager, 2009; van Praag et al., 2004).

#### Heritability and Familial Risk

Family studies have robustly demonstrated that MDD runs in families. First-degree relatives of individuals with MDD have a significantly higher risk of developing the disorder compared to the general population (Cadoret & Winokur, 1972). Parental depression is one of the most potent risk factors for depression in offspring, contributing both a genetic predisposition and potentially an emotionally challenging environment (Prager, 2009; Stearns et al., 2024). The risk is further elevated when both parents have a history of mood disorders (Dodd, 2007). Twin studies, which compare the concordance rates between monozygotic (identical) and dizygotic (fraternal) twins, provide a clearer estimate of heritability. Such studies suggest that genetic factors account for a substantial portion of the variance in liability to depression, although the exact heritability estimates vary (Dodd, 2007). The genetic influence appears to be greater for adolescent-onset depression than for prepubertal depression (Prager, 2009).

This familial aggregation is not limited to depression alone. Studies have found an increased prevalence of other psychiatric conditions, such as alcoholism, in the families of patients with affective disorders, suggesting a shared genetic liability for a spectrum of related conditions (Cadoret & Winokur, 1972; Osgood, 1991). The search for specific susceptibility genes for MDD has been challenging due to the disorder's heterogeneity and the likelihood that it is polygenic, meaning many genes of small effect contribute to the overall risk (Dodd, 2007). While research into severe mental illnesses like schizophrenia has implicated multiple chromosomal linkages, the specific genetic architecture of MDD remains an area of intensive investigation (Dodd, 2007). One hypothesis suggests that the combination of the shorter allelic form of the serotonin transporter gene with adverse life events leads to early-onset depression, highlighting a gene-environment interaction (Prager, 2009).

#### Molecular Pathways and Cellular Mechanisms

At the molecular level, the pathophysiology of MDD is thought to involve disruptions in intracellular signaling cascades, gene expression, and neurotrophic factors, which ultimately lead to impairments in neuroplasticity and cellular resilience (Hadi et al., 2017). Chronic stress, a key environmental risk factor, plays a crucial role in initiating these molecular changes (van Praag et al., 2004).

As discussed previously, hyperactivity of the HPA axis and elevated cortisol levels are common in depression (Goodyer et al., 2000). Prolonged exposure to stress hormones can alter the expression of genes involved in neuronal survival and plasticity (van Praag et al., 2004). One of the most studied molecular pathways involves neurotrophic factors, particularly brain-derived neurotrophic factor (BDNF). BDNF is critical for neuronal growth, differentiation, and survival. Chronic stress and high cortisol levels have been shown to decrease BDNF expression, particularly in the hippocampus, a key brain region for memory and mood regulation (Sandi, 2013). This reduction in BDNF may contribute to the hippocampal atrophy observed in some individuals with recurrent depression (Ruiz-Rizzo & Lópera Restrepo, 2008). Conversely, antidepressant treatments, including both pharmacotherapy and electroconvulsive therapy (ECT), have been found to increase BDNF levels and promote neurogenesis (the birth of new neurons) in the hippocampus (Novati, 2012). This suggests that restoring neurotrophic support and enhancing neuroplasticity may be a common final pathway for the therapeutic action of antidepressants (Hadi et al., 2017).

Inflammatory processes also represent a significant molecular pathway in depression. An association between depression and an increase in pro-inflammatory cytokines, such as interleukin-1, interleukin-6, and tumor necrosis factor-alpha, has been described (Trill, 2012). Both the psychological stress that often precedes depression and the cancer disease process itself can trigger the production of these cytokines, which may in turn contribute to the development of depressive symptoms, including fatigue, anhedonia, and cognitive changes (Trill, 2012; Riba & Grassi, 2008). This "sickness behavior" induced by inflammation shares many phenomenological features with depression, suggesting that immune dysregulation is an important component of the disorder's pathophysiology in at least a subset of patients (Patten, 2015).

Furthermore, metabolic and endocrine dysregulation are deeply intertwined with the molecular basis of MDD. Alterations in glucose metabolism, insulin resistance, and thyroid function are frequently observed in depressed individuals and can reciprocally influence mood (Schenck, 2003; Isgin & Büyüktuncer, 2017). For example, thyroid dysfunction can mimic or precipitate depressive symptoms (Burgoyne et al., 1995; Satoh-Kuriwada et al., 2009), and hormonal fluctuations associated with the menstrual cycle, pregnancy, and menopause are known periods of increased vulnerability to depression for women (Abay & Kaplan, 2019; Bromberger, 1998; Wakil et al., 2012). These connections highlight the systemic nature of the disorder, where disruptions in central neurotransmitter systems are linked to broader changes in the body's endocrine, immune, and metabolic signaling pathways (Koo, 2018).

### Brain Structure and Function

Converging evidence from neuroimaging and neuropathological studies indicates that Major Depressive Disorder is associated with observable changes in the structure and function of specific brain regions and the neural circuits that connect them (Hadi et al., 2017). These alterations are thought to underlie the cognitive, emotional, and somatic symptoms characteristic of the disorder. The brain areas most consistently implicated form a network involving the prefrontal cortex, limbic system structures like the hippocampus and amygdala, and subcortical regions such as the thalamus and basal ganglia (Dodd, 2007; Sandi, 2013).

#### Structural Neuroimaging Findings

Structural neuroimaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT), have revealed subtle but significant anatomical differences in individuals with MDD compared to healthy controls. One of the most frequently reported findings is a reduction in the volume of the hippocampus (Ruiz-Rizzo & Lópera Restrepo, 2008; Novati, 2012). The hippocampus is a critical structure within the limbic system, heavily involved in learning, memory, and the regulation of the stress response (Sandi, 2013). The volume loss observed in depression is thought to be a consequence of the neurotoxic effects of chronic stress and elevated cortisol levels, which can suppress neurogenesis and lead to neuronal atrophy (Ruiz-Rizzo & Lópera Restrepo, 2008; Novati, 2012). This hippocampal atrophy may, in turn, contribute to the memory and cognitive deficits frequently reported by depressed individuals (Gohier et al., 2009; Xie et al., 2012).

The prefrontal cortex (PFC), particularly its medial and orbital subregions, also shows structural changes in depression (Sandi, 2013; Dodd, 2007). The PFC is central to executive functions, such as planning, decision-making, and emotional regulation (Krolak-Salmon & Thomas-Antérion, 2010). Volumetric reductions in areas like the orbitofrontal cortex and anterior cingulate cortex have been linked to the persistent negative cognitions, rumination, and difficulties with emotional control seen in MDD (Sandi, 2013; van Praag et al., 2004). Other structural findings include ventricular enlargement and sulcal widening in some studies, suggesting more diffuse brain volume loss, though these findings are not as consistent as those in the hippocampus and PFC (Dodd, 2007). It is important to note that these structural changes are not universal and may be more prominent in individuals with recurrent, chronic, or late-life depression (Ruiz-Rizzo & Lópera Restrepo, 2008; Sekhon et al., 2019).

#### Functional Neuroimaging and Connectivity

Functional neuroimaging techniques, such as positron emission tomography (PET) and functional MRI (fMRI), assess brain activity by measuring cerebral blood flow or metabolism. These studies have provided crucial insights into the neural circuits that are dysregulated in MDD. A consistent finding is altered activity within a network of limbic and cortical regions (Chen & Gong, 2021).

Specifically, many studies report hyperactivity in ventral and medial parts of the PFC, including the subgenual anterior cingulate cortex and the amygdala, during depressive states (van Praag et al., 2004). The amygdala is a key node for processing fear and threat-related stimuli, and its heightened activity is thought to contribute to the anxiety, negative emotional bias, and hypervigilance common in depression (Praag, 1998). This limbic hyperactivity is often accompanied by hypoactivity in dorsal and lateral regions of the PFC, such as the dorsolateral prefrontal cortex (DLPFC) (Dodd, 2007). The DLPFC is involved in cognitive control and executive function, and its reduced activity is linked to the cognitive symptoms of depression, including impaired concentration, indecisiveness, and psychomotor retardation (Culpepper, 2015; Paunescu & Micluția, 2012). This pattern of limbic hyperactivity and dorsal cortical hypoactivity suggests a failure of "top-down" cognitive control over emotional processing, a central theme in the neurobiology of depression (van Praag et al., 2004).

Resting-state functional connectivity studies, which examine the temporal correlation of activity between different brain regions when an individual is not engaged in a specific task, have further elucidated the network-level disruptions in MDD (Chen & Gong, 2021). These studies often identify altered connectivity within the default mode network (DMN), a set of brain regions that is active during self-referential thought and rumination. In depression, the DMN often shows increased connectivity, which may be the neural correlate of the persistent and intrusive negative self-focused thoughts characteristic of the disorder (Chen & Gong, 2021; Nolen-Hoeksema, 1998).

Electrophysiological studies using electroencephalography (EEG) also reveal functional abnormalities. Depressed patients often show changes in sleep EEG, such as reduced slow-wave sleep and REM sleep abnormalities, reflecting dysregulation of brainstem and hypothalamic sleep-regulating centers (Dodd, 2007; Mellman, 1989). Furthermore, studies of event-related potentials, such as the P300 component, which reflects cognitive processes like attention and working memory, have shown alterations in depressed individuals, consistent with their cognitive complaints (Korepina et al., 1998). These findings collectively paint a picture of MDD as a disorder of disrupted brain networks, where an imbalance between emotional processing and cognitive control circuits leads to the pervasive symptoms of the illness.

### Developmental Neurobiology

Major Depressive Disorder can emerge at any point across the lifespan, from early childhood through late life, and its presentation and underlying neurobiology are profoundly influenced by developmental processes (Prager, 2009; Stubbe, 2007). The developing brain is particularly vulnerable to the interplay of genetic predispositions and environmental stressors, which can shape neural circuits and establish trajectories toward or away from psychopathology (Gleason et al., 2022; van Praag et al., 2004).

#### Depression in Childhood and Adolescence

Once considered a uniquely adult phenomenon, it is now firmly established that MDD can and does occur in children and adolescents, with prevalence rates rising sharply during the teenage years (Hatcher-Kay & King, 2003; Vashishta, 2022). Prior to puberty, depression rates are roughly equal between boys and girls; however, after puberty, a consistent 2:1 female-to-male ratio emerges, which persists into adulthood (Hatcher-Kay & King, 2003; Bromberger, 1998). The onset of depression during these critical developmental periods can significantly interfere with academic performance, peer relationships, and the acquisition of social and emotional competencies (Evans et al., 2002; Prager, 2009).

The clinical presentation of depression varies with developmental stage (Prager, 2009). While sadness and anhedonia are core features, prepubertal children are more likely to present with irritability, anger, somatic complaints (such as stomachaches and headaches), and social withdrawal (Vashishta, 2022; Gleason et al., 2022; Prager, 2009). Behavioral problems, including oppositional defiance or even conduct disorder, may mask an underlying mood disorder (Prager, 2009; Gottlieb & Friedman, 1991). In adolescents, symptoms may more closely resemble the adult presentation, but moodiness, impulsivity, and erratic behavior, which can be part of normal adolescence, can make diagnosis challenging (Prager, 2009). Substance abuse may emerge as a form of self-medication, complicating the clinical picture (Hatcher-Kay & King, 2003). Early-onset dysthymic disorder, a chronic but less severe form of depression, can also begin in childhood or adolescence, often presenting as persistent irritability and low self-esteem (Thase & Lang, 2004).

#### Critical Periods and Neurodevelopmental Trajectories

The concept of critical or sensitive periods in development is highly relevant to the etiology of MDD. Exposure to significant adversity during these periods, such as childhood abuse, neglect, or loss of a parent, is a potent risk factor for the later development of depression and other psychiatric disorders (Bouras & Lazaratou, 2012; Prager, 2009). Such early life stress can have long-lasting organizational effects on the developing brain, particularly on the HPA axis and neural circuits involved in emotion regulation (Charmandari et al., 2003; van der Kolk, 1998). This can lead to a state of heightened biological vulnerability to stress in later life, where subsequent, even minor, stressors can precipitate a depressive episode (van Praag et al., 2004).

Neurodevelopmental disorders such as Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD) are frequently comorbid with depression (Burgić Radmanović & Burgić, 2020; Gleason et al., 2022). The cognitive and social challenges associated with these conditions can be significant stressors, contributing to feelings of failure, social isolation, and low self-esteem, which in turn increase the risk for depression (Hawes & Scalise, 2005). Shared genetic factors and overlapping neural pathways, particularly those involving frontal-striatal circuits that regulate attention and impulse control, may also contribute to this comorbidity (Mohammadi & Akhondzadeh, 2007; Dodd, 2007).

The adolescent brain undergoes significant maturational changes, including synaptic pruning and myelination, particularly in the prefrontal cortex, which is responsible for executive functions and emotional control (Sharma et al., 2014). This period of heightened neuroplasticity may represent another critical window of vulnerability. Hormonal changes during puberty also have a profound impact on brain development and mood regulation, potentially contributing to the increased incidence of depression, especially in girls (Hatcher-Kay & King, 2003). Genetic risk factors appear to play a greater role in adolescent-onset depression compared to childhood-onset forms (Prager, 2009), suggesting that the interaction between maturing biological systems and the increasing psychosocial demands of adolescence is a key driver of the disorder's emergence. Understanding these developmental pathways is crucial for designing effective prevention and early intervention strategies aimed at mitigating the long-term impact of MDD (Evans et al., 2002).

### Treatment Mechanisms

The treatment of Major Depressive Disorder involves a range of interventions, primarily pharmacotherapy and psychotherapy, which are believed to exert their therapeutic effects by targeting the underlying biological dysfunctions of the disorder. Insights into how these treatments work provide a crucial window into the neurobiology of MDD itself.

#### Pharmacological Interventions

The mainstay of pharmacological treatment for MDD is antidepressant medication, with different classes of drugs acting on specific neurotransmitter systems (Kotade et al., 2011). As previously noted, the efficacy of these agents forms the basis of the monoamine hypothesis of depression (Nayudu Teja et al., 2020).

Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed first-line agents (Akram et al., 2023; Trivedi et al., 2020). By blocking the serotonin transporter, SSRIs increase the concentration of serotonin in the synapse, enhancing serotonergic neurotransmission (Gordon, 2014; Rosenbaum & Zajecka, 1997). This action is thought to gradually lead to downstream adaptive changes in receptor sensitivity and intracellular signaling, which correlate with clinical improvement (Gordon, 2014). Serotonin-norepinephrine reuptake inhibitors (SNRIs) have a dual mechanism, blocking the reuptake of both serotonin and norepinephrine, thereby modulating two key monoamine systems implicated in mood regulation (Trivedi et al., 2020; Akram et al., 2023). Tricyclic antidepressants (TCAs) also affect these two neurotransmitters, but their broader action on other receptors (such as histamine and acetylcholine) contributes to a less favorable side-effect profile (Edwards, 1995; Hindmarch, 1998). The clinical response to these medications is typically delayed, often taking several weeks to become apparent, suggesting that the therapeutic effect is not simply due to the acute increase in neurotransmitter levels but rather to slower, neuroplastic changes that these drugs initiate (Pies, 2007; Gordon, 2014).

Other pharmacological agents target different systems. For instance, some atypical antipsychotics, which have complex actions on dopamine and serotonin receptors, are used as augmenting agents in treatment-resistant depression, highlighting the role of dopaminergic pathways (Dodd, 2007; Montes & Rey, 2009). The rapid antidepressant effects of ketamine, an NMDA receptor antagonist, have shifted focus toward the glutamatergic system, suggesting that modulating excitatory neurotransmission may offer a novel and faster-acting treatment mechanism (Ghaisani, 2018).

#### Neurostimulation and Other Biological Treatments

For severe or treatment-resistant depression, neurostimulation techniques are effective options. Electroconvulsive therapy (ECT) is one of the most potent treatments for severe, psychotic, or catatonic depression (Kotade et al., 2011; Fink, 2010). Although its exact mechanism is not fully understood, ECT is known to induce widespread neurochemical changes, including enhancing dopamine and serotonin transmission and increasing the release of neurotrophic factors like BDNF (Kotade et al., 2011; Novati, 2012). It also appears to "reset" dysfunctional neural circuits, normalizing patterns of brain connectivity (Fink, 2010).

Deep brain stimulation (DBS), a more targeted neurosurgical approach, involves implanting electrodes in specific brain regions, such as the subgenual cingulate cortex or the ventral capsule/ventral striatum (Holtzheimer & Hamani, 2014). These areas are key nodes in the cortico-limbic circuits that are dysregulated in depression. DBS is thought to work by modulating the activity of these dysfunctional circuits, essentially correcting the pathological patterns of brain activity associated with chronic depression (Holtzheimer & Hamani, 2014).

#### Non-Pharmacological Interventions

Psychotherapies, such as cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT), are also first-line treatments for MDD (Hatcher-Kay & King, 2003). While primarily psychological in their approach, these therapies are believed to induce biological changes in the brain. CBT, which focuses on identifying and modifying negative thought patterns and maladaptive behaviors, has been shown to alter activity in the prefrontal cortex and limbic regions, similar to the effects of antidepressants (Barroso Martínez, 2019; Barnhofer and Fennell, 2008). By teaching new coping skills and cognitive restructuring, CBT may strengthen top-down regulatory control from the PFC over hyperactive limbic structures (Sánchez Muñoz de León, 2017).

Physical activity and exercise are increasingly recognized as effective interventions for depression, particularly for mild to moderate forms (Cakmak, 2024; Smith & Blumenthal, 2015). The biological mechanisms are likely multifactorial, involving an increase in monoamine neurotransmitters, release of endorphins, and enhancement of neurotrophic factors like BDNF (Chaouloff et al., 2013; Cakmak, 2024). Exercise also helps regulate the HPA axis, reducing the hypercortisolemia associated with stress and depression, and can improve sleep quality and circadian rhythm stability (Smith & Blumenthal, 2015).

Furthermore, chronotherapeutic interventions, which directly target the disturbed circadian system in depression, have shown efficacy. Sleep deprivation, particularly in the second half of the night, can produce a rapid antidepressant effect in many patients, though it is often transient (Dessauer et al., 1985; Wirz-Justice, 2003). Bright light therapy, the standard treatment for seasonal affective disorder, also has antidepressant properties in nonseasonal depression, likely by helping to reset and stabilize the circadian pacemaker (Wirz-Justice, 1986; Wirz-Justice, 2003). These treatments underscore the integral role of sleep and circadian biology in the pathophysiology and resolution of depressive episodes.

### Future Directions

Despite significant advances in understanding the biological underpinnings of Major Depressive Disorder, many critical questions remain unanswered. The field is moving towards a more nuanced and integrated perspective, recognizing the profound heterogeneity of the disorder and the need for personalized medicine approaches. Future research is poised to explore several key areas that promise to refine our diagnostic capabilities, enhance treatment efficacy, and deepen our mechanistic understanding.

One of the most significant challenges is the clinical and biological heterogeneity of MDD (Patten, 2015). The current diagnostic criteria group together individuals with diverse symptom clusters, underlying pathophysiologies, and treatment responses (Kennedy, 2008). A crucial future direction is the identification of distinct biological subtypes, or "biotypes," of depression. This could be achieved by integrating multi-modal data, including genetics, neuroimaging, electrophysiology (e.g., EEG), and peripheral biomarkers (e.g., inflammatory markers, cortisol levels) (Surova et al., 2020). For example, differentiating patients based on their level of brain arousal (hyperaroused vs. hypoaroused) may identify subgroups with distinct clinical features, such as different types of fatigue or varying levels of suicidal ideation, and potentially different treatment needs (Surova et al., 2020). Similarly, identifying patients with a predominantly inflammatory or metabolic subtype of depression could guide the use of targeted anti-inflammatory or metabolic interventions (Trill, 2012).

The search for reliable and valid biomarkers is a central goal. While group-level differences in brain structure and function have been identified, their predictive value for individual diagnosis, prognosis, or treatment selection is still limited (Chen & Gong, 2021). Future neuroimaging research will likely focus on large-scale, longitudinal studies to track brain changes over time and identify markers that predict illness onset, recurrence, and response to specific treatments (Ruiz-Rizzo & Lópera Restrepo, 2008). Advanced imaging techniques may help elucidate the functional consequences of structural abnormalities and the precise network dynamics that are disrupted in different depressive subtypes.

In the realm of genetics, the shift from candidate gene studies to genome-wide association studies (GWAS) has begun to yield more robust findings, but the identified risk variants have small individual effects, confirming the polygenic nature of MDD (Dodd, 2007). Future work will need to move beyond simply identifying risk genes to understanding their function within specific neural circuits and how they interact with environmental factors. The study of epigenetics—how environmental experiences like early life stress can modify gene expression without changing the DNA sequence itself—is a particularly promising avenue for understanding the mechanisms of gene-environment interaction (Bouras & Lazaratou, 2012; van Praag et al., 2004).

Improving treatment outcomes, especially for the significant proportion of patients who do not respond to initial therapies (treatment-resistant depression), is a paramount clinical and research priority (Holtzheimer & Hamani, 2014). This requires a better understanding of the neurobiology of treatment resistance. Research into novel therapeutic targets beyond the monoamine systems is rapidly expanding. The success of ketamine has spurred intense investigation into the glutamatergic system (Ghaisani, 2018). Other promising targets include the inflammatory system, the gut-brain axis, and neurotrophic signaling pathways (Ávila Suárez, 2022; Han & Jung, 2025). The development of new pharmacological agents, such as positive allosteric modulators of GABA-A receptors, offers new hope for conditions like postpartum depression and may provide insights applicable to MDD more broadly (Akram et al., 2023).

Finally, a more integrated, transdiagnostic approach is needed. The high rate of comorbidity between depression and other conditions, such as anxiety disorders, substance use disorders, and physical illnesses, suggests shared underlying biological mechanisms (Kasper, 2006; Hatcher-Kay & King, 2003; Issa, 2013). Research that examines these shared vulnerabilities, rather than studying disorders in isolation, may reveal fundamental principles of brain dysfunction that can be targeted for both treatment and prevention. The ultimate goal is to move from a "one-size-fits-all" approach to a biologically informed, personalized strategy for the prevention and treatment of MDD.

### Conclusion

Major Depressive Disorder is a complex and heterogeneous illness rooted in a multifaceted interplay of biological, psychological, and social factors (Quintana Coronado et al., 2017). This chapter has synthesized the current understanding of the neurobiological foundations of MDD, drawing upon a diverse body of evidence. The accumulated research strongly indicates that MDD is a systemic disorder of the brain and body, characterized by demonstrable and significant disruptions in neurochemistry, neural circuitry, endocrine function, and circadian regulation (Kotade et al., 2011; Hadi et al., 2017).

The monoamine hypothesis, which implicates deficiencies in serotonin, norepinephrine, and dopamine, remains a cornerstone of our understanding, largely due to the efficacy of antidepressant medications that target these systems (Nayudu Teja et al., 2020; Trivedi et al., 2020). However, it is increasingly clear that this is an oversimplification. The delayed onset of action of these drugs points to more complex, downstream neuroplastic adaptations as the true mediators of therapeutic change (Pies, 2007). Dysregulation of the HPA axis, evidenced by hypercortisolemia and an impaired stress response, is a key biological signature in many individuals with depression, linking environmental stressors to tangible neuroendocrine changes (van Praag et al., 2004; Goodyer et al., 2000). Furthermore, the pervasive sleep and circadian rhythm disturbances seen in MDD are not mere epiphenomena but reflect fundamental disruptions in the brain's timekeeping and homeostatic mechanisms (Wirz-Justice, 1986; Latta & Cauter, 2003).

Neuroimaging has provided a window into the structural and functional brain changes associated with MDD, highlighting a dysfunctional network involving limbic areas like the amygdala and hippocampus, and crucial regulatory regions in the prefrontal cortex (Chen & Gong, 2021; Sandi, 2013). This altered connectivity is believed to underpin the emotional dysregulation and cognitive deficits that define the disorder (Culpepper, 2015). Genetic research confirms that vulnerability to depression is heritable, resulting from the cumulative effect of many genes interacting with environmental exposures, particularly during critical neurodevelopmental periods (Prager, 2009; Gleason et al., 2022).

While our understanding has grown immensely, the precise etiology of MDD remains elusive, and the heterogeneity of the disorder presents a significant challenge for both research and clinical practice (Patten, 2015). The current diagnostic framework likely encompasses multiple distinct biological subtypes that require different therapeutic approaches. The future of research in this field lies in identifying these biotypes through the integration of genetic, imaging, and molecular data, paving the way for a new era of personalized psychiatric medicine. By continuing to unravel the complex biological tapestry of depression, we can move toward more effective, targeted treatments and, ultimately, prevention strategies that can alleviate the profound burden of this devastating illness.

### References
- Abad, A., Matesanz, C. M., Acosta, C. R. D., & López, C. M. (2022). Sleep apnoea and sleep disorders. Pathy's Principles and Practice of Geriatric Medicine. https://doi.org/10.1002/9781119484288.ch45
- Abay, H., & Kaplan, S. (2019). Current Approaches in Premenstrual Syndrome Management. Bezmialem Science. https://doi.org/10.14235/bas.galenos.2018.2358
- AbdulRahman, I., Yaqoob, Ú., & Bhatti, T. A. (2018). Sleep Disorders Caused by Depression. Clinical Depression. https://doi.org/10.4172/2572-0791.1000131
- Abe, Y., & Germai, A. (2012). Insomnia and Its Correlates: Current Concepts, Epidemiology, Pathophysiology and Future Remarks. InTech eBooks. https://doi.org/10.5772/36102
- Adams, B., & Bromley, B. (1998). Loss and grief therapy. https://doi.org/10.1007/978-1-349-26634-0_10
- Adès, J., & Lejoyeux, M. (1993). [Psychiatric emergencies in acute alcoholic intoxication].. PubMed.
- Adès, J., & Lejoyeux, M. (1997). [Intermittent alcoholic behavior].. PubMed.
- Adler, G. (2006). Diagnostik der Demenz. Notfall & Hausarztmedizin (Notfallmedizin). https://doi.org/10.1055/s-2006-959110
- Aghababaeian, H., & Ahvazi, L. A. (2018). Isn’t it Time to Use Opioid Drugs in Emergency Medical Services?. DOAJ (DOAJ: Directory of Open Access Journals).
- Ainsworth, P. (1998). Attention deficit hyperactivity disorder: diagnostic issues. Morecambe Bay medical journal. https://doi.org/10.48037/mbmj.v3i2.541
- Aitken, R. C. B. (1975). Psychological medicine. Stress and distress.. BMJ. https://doi.org/10.1136/bmj.1.5958.611
- Ajiboye, P., & Yusuf, A. D. (2013). Scientific Letter: Monosymptomatic Hypochondriacal Psychosis (somatic delusional disorder): A report of two cases. African Journal of Psychiatry. https://doi.org/10.4314/ajpsy.v16i2.11
- Ak, A. K., Sarıtaş, A. Ş., Gemici, Y. İ., & Yılmaz, H. (2022). Clinical Approach Hypersomnia of Central Origin and Differential Diagnosis. Journal of Turkish Sleep Medicine. https://doi.org/10.4274/jtsm.galenos.2022.07279
- AKTAŞ, S., & Karaaziz, M. (2022). COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF DEPRESSION: A CASE REPORT. SOCIAL SCIENCE DEVELOPMENT JOURNAL. https://doi.org/10.31567/ssd.763
- Akram, A. S., Sarwar, R., Zafar, M. F., Umair, M., Ullah, I., & Nazir, A. (2023). First oral treatment zuranolone’s FDA approval and its impact on postpartum depression: a new hope – a correspondence. International Journal of Surgery Global Health. https://doi.org/10.1097/gh9.0000000000000345
- Alarcón, V. A. G. (2010). Niños inteligentes que no progresan. Niños desatentos. Revista internacional de investigación en ciencias sociales.
- Albano, A. M., & Silverman, W. K. (2024). Bipolar Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348367.003.0017
- Albano, A. M., & Silverman, W. K. (2024). Bipolar Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348381.003.0016
- Albano, A. M., & Silverman, W. K. (2024). Disruptive Mood Dysregulation Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348367.003.0016
- Albano, A. M., & Silverman, W. K. (2024). Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348367.003.0014
- Albano, A. M., & Silverman, W. K. (2024). Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348381.003.0014
- Albano, A. M., & Silverman, W. K. (2024). Obsessive-Compulsive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348367.003.0012
- Albano, A. M., & Silverman, W. K. (2024). Obsessive-Compulsive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348381.003.0012
- Albano, A. M., & Silverman, W. K. (2024). Panic Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780199348381.003.0010
- Alchieri, J. C., & Urquijo, S. (2022). Aspectos demenciais frontotemporais como desafios em processos periciais psicológicos. Revista Psicologia Jurídica Forense. https://doi.org/10.56492/issn.27647374.2022n1a1
- Alderton, H. R. (1966). A Review of Schizophrenia in Childhood. Canadian Psychiatric Association Journal. https://doi.org/10.1177/070674376601100403
- Alessi, C., & Vitiello, M. V. (2015). Insomnia (primary) in older people: non-drug treatments.. PubMed.
- Ali, N., Rasheed, A., Tariq, I., Abdullah, F., Sarwar, A., Atta, R., & Qammer, Z. (2018). Adjunct Use of Low Dose Risperidone Verses Adjunct Use of Clonazepam with an SSRI in Treatment of Moderate to Severe Anxiety States; A Comparative Study. National Journal of Health Sciences. https://doi.org/10.21089/njhs.32.0051
- Alli, R., Hall, D., Clarke, P., Hugenschmidt, C. E., Rogers, S., Sink, K. M., Villalba, J., Williams, J., Wilson, V., & Shaw, E. (2013). P3–244: An interdisciplinary counseling center for individuals, couples and families affected by MCI and dementia. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2013.05.1317
- Allison, K. C., & Berner, L. A. (2013). Behavioral management of night eating disorders. Psychology Research and Behavior Management. https://doi.org/10.2147/prbm.s31929
- Alloy, L. B., & Abramson, L. Y. (2010). Cyclothymic Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0249
- Alonso-Fernández, F. (2009). Las cuatro dimensiones del enfermo depresivo. Salud Mental.
- Alshehri, S., & Lega, I. C. (2025). The Impact Of Menopause On The Musculoskeletal System: A Practical Overview. Canadian Women s Health Today. https://doi.org/10.58931/cwht.2025.2120
- Alt, M. (2011). Lethargie bei Hungernden; Überlebensstrategie oder klinische Depression? Kognitive und psychovegetative Depressionssymptome im Hungerstoffwechsel unter besonderer Berücksichtigung der Anorexia Nervosa.
- Alvarenga, P. G. D., Hounie, A. G., Mercadante, M. T., Miguel, E. C., & Rosário, M. C. D. (2007). Obsessive-compulsive disorder: A historical overview.. https://doi.org/10.4324/9780203936870-7
- Ameena, B. B. (2021). An Overview of Stress Management. Shanlax International Journal of Arts Science and Humanities. https://doi.org/10.34293/sijash.v8is1-feb.3956
- Amiel, C., & Purper‐Ouakil, D. (2020). [What prescription for psychostimulants in children?]. PubMed.
- Amorim, M. J., Maurício, J., & Brandão, D. (2019). WHEN THE DISEASE ARISES FROM THE TREATMENT: CORTICOSTEROID-INDU...

## References

1. Abad, A., Matesanz, C. M., Acosta, C. R. D., & López, C. M. (2022). Sleep apnoea and sleep disorders. Pathy's Principles and Practice of Geriatric Medicine. https://doi.org/10.1002/9781119484288.ch45
2. Abay, H., & Kaplan, S. (2019). Current Approaches in Premenstrual Syndrome Management. Bezmialem Science. https://doi.org/10.14235/bas.galenos.2018.2358
3. Abdelsayed, S., Acevedo, R., & Clemow, L. (2017). Is sleep deprivation associated with behavioral changes in children and adolescents?. Evidence-Based Practice. https://doi.org/10.1097/01.ebp.0000541629.93211.cb
4. Adam, S., & Osborne, S. (2009). Chapter 21 Metabolic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199215904.003.21
5. Adams, B., & Bromley, B. (1998). Loss and grief therapy. https://doi.org/10.1007/978-1-349-26634-0_10
6. Ademi, L. A., & Ademi, B. (2017). EVALUATION AND MANAGEMENT OF A CHILD WITH FEBRILE SEIZURE.
7. Ainsworth, P. (1998). Attention deficit hyperactivity disorder: diagnostic issues. Morecambe Bay medical journal. https://doi.org/10.48037/mbmj.v3i2.541
8. Akram, A. S., Sarwar, R., Zafar, M. F., Umair, M., Ullah, I., & Nazir, A. (2023). First oral treatment zuranolone’s FDA approval and its impact on postpartum depression: a new hope – a correspondence. International Journal of Surgery Global Health. https://doi.org/10.1097/gh9.0000000000000345
9. AKTAŞ, S., & Karaaziz, M. (2022). COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF DEPRESSION: A CASE REPORT. SOCIAL SCIENCE DEVELOPMENT JOURNAL. https://doi.org/10.31567/ssd.763
10. Alberdi-Páramo, Í., & Pelaz-Antolín, A. (2019). Emocionalidad y temperamento en el trastorno por déficit de atención con o sin hiperactividad. Revista de Neurología. https://doi.org/10.33588/rn.6908.2019032
11. Alchieri, J. C., & Urquijo, S. (2022). Aspectos demenciais frontotemporais como desafios em processos periciais psicológicos. Revista Psicologia Jurídica Forense. https://doi.org/10.56492/issn.27647374.2022n1a1
12. Alessi, C., & Vitiello, M. V. (2015). Insomnia (primary) in older people: non-drug treatments.. PubMed.
13. Alli, R., Hall, D., Clarke, P., Hugenschmidt, C. E., Rogers, S., Sink, K. M., Villalba, J., Williams, J., Wilson, V., & Shaw, E. (2013). P3–244: An interdisciplinary counseling center for individuals, couples and families affected by MCI and dementia. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2013.05.1317
14. Allison, K. C., & Berner, L. A. (2013). Behavioral management of night eating disorders. Psychology Research and Behavior Management. https://doi.org/10.2147/prbm.s31929
15. Alvarenga, P. G. D., Hounie, A. G., Mercadante, M. T., Miguel, E. C., & Rosário, M. C. D. (2007). Obsessive-compulsive disorder: A historical overview.. https://doi.org/10.4324/9780203936870-7
16. Ameena, B. B. (2021). An Overview of Stress Management. Shanlax International Journal of Arts Science and Humanities. https://doi.org/10.34293/sijash.v8is1-feb.3956
17. Amores, F. B. C., Pérez, G. P. L., Torres, N. A. C., & Carpio, V. D. P. C. (2023). Sleep pattern impairment in nursing students according to NANDA. Medwave. https://doi.org/10.5867/medwave.2023.s1.uta111
18. Amorim, M. J., Maurício, J., & Brandão, D. (2019). WHEN THE DISEASE ARISES FROM THE TREATMENT: CORTICOSTEROID-INDUCED PSYCHOSIS A CASE REPORT AND BRIEF LITERATURE REVIEW. https://doi.org/10.26226/morressier.5d1a037b57558b317a140b63
19. Ananto, A. S., & Suryati, E. (2019). Ensefalopati Hipertensi pada Anak dengan Glomerulonefritis Akut Pasca Streptokokal.
20. Anggela, S., & Hanum, N. A. (2020). HUBUNGAN KEBIASAAN BURUK ORAL (BAD ORAL HABITS) DENGAN KARIES PADA ANAK USIA PRA-SEKOLAH.
21. Antoniuk, S. A. (2013). [Non-epileptic disorders in infancy and adolescence].. PubMed.
22. Apter, A. (2000). Personality constellations in suicidal behavior. Éditions GREUPP eBooks. https://doi.org/10.3917/greu.isap.2000.01.0263
23. Aracena, M. (2019). La formación profesional del cuidador de personas con deterioro cognitivo y demencias. Séptimo Congreso Internacional de Investigación en Psicología.
24. Arango, C., & Pina‐Camacho, L. (2021). Trends in utilisation of hypnotics among Scandinavian young people. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.13341
25. Arendt, J. (2000). Melatonin, Circadian Rhythms, and Sleep. New England Journal of Medicine. https://doi.org/10.1056/nejm200010123431510
26. Arenson, C., Busby‐Whitehead, J., Brummel‐Smith, K., O’Brien, J. G., Palmer, M. H., & Reichel, W. (2010). Evaluation and Management of Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511575952.017
27. Argilés, J. M., Busquets, S., López‐Soriano, F. J., & Fernández‐Figueras, M. T. (2006). Fisiopatología de la caquexia neoplásica. Nutrición Hospitalaria.
28. Ariff, K. M., & Hassan, Z. A. (2006). Insomnia: Case Studies In Family Practice.. DOAJ (DOAJ: Directory of Open Access Journals).
29. Armstrong, E. (1995). Anxiety and related problems. https://doi.org/10.1007/978-1-349-13362-8_5
30. Armstrong, L. E., Casa, D. J., Millard‐Stafford, M., Moran, D. S., Pyne, S. W., & Roberts, W. O. (2007). Exertional Heat Illness during Training and Competition. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/mss.0b013e31802fa199
31. Arnáez, S. (2019). Vulnerabilidad cognitiva a la hipocondría: intrusiones, valoraciones y creencias disfuncionales/ cognitive vulnerability to hypochondriasis: intrusions, appraisals and dysfunctional beliefs.
32. Arteaga, T. L., Amo, C., González, C. S., & Sánchez, D. H. (2013). Nonconvulsive status epilepticus and psychotic symptoms: case report.. PubMed. https://doi.org/10.1708/1292.14295
33. Ashton, H. (1994). The treatment of benzodiazepine dependence. Addiction. https://doi.org/10.1111/j.1360-0443.1994.tb03755.x
34. Avendaño, M. L. P., Rincón, C. M., Tejada, J. V., & Etchepareborda, M. C. (2020). Variantes de neurodesarrollo en pacientes con diagnóstico de agenesia del cuerpo calloso completa y parcial. Revista Neuropsicologia Latinoamericana.
35. Awan, K., & Steinberg, M. H. (2017). Medical Conditions That May Cause Cognitive Impairment and Depression. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199959549.003.0005
36. Aydın, S. (2020). Attention Deficit and Hyperactivity Disorder May be Linked to Renalase Enzyme Amount Synthesized in Brain.
37. Ayoob, A., & Janakiram, C. (2021). Let's Focus on Frailty. Journal of Indian Association of Public Health Dentistry. https://doi.org/10.4103/jiaphd.jiaphd_93_21
38. Azaraeen, S., & Memarian, S. (2015). Comparison of cognitive failures in addicts and non addicts. https://doi.org/10.1109/cogsci.2015.7426663
39. B.R, R., & N.K.C, E. (2019). A review on pain and its signals modulation by body. IP International Journal of Comprehensive and Advanced Pharmacology. https://doi.org/10.18231/j.ijcaap.2019.018
40. Ba, V. D. K. (1998). [Psychology and psychobiology of childhood trauma].. PubMed.
41. Bachmann, C. (2015). Padma 28 bei Restless-Legs-Syndrom: Fallberichte wecken Hoffnungen auf Wirksamkeit. Schweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine. https://doi.org/10.1159/000434622
42. Bains, N., Abdijadid, S., & Miller, J. (2021). Major Depressive Disorder (Nursing).
43. Baird, T. M., Martin, R. J., & Abu‐Shaweesh, J. M. (2002). Clinical Associations, Treatment, and Outcome of Apnea of Prematurity. NeoReviews. https://doi.org/10.1542/neo.3-4-e66
44. Bakheet, M. R., & Boyce, H. W. (2005). Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease.. PubMed.
45. Balaban, M. T., & Berg, W. K. (2007). Measuring the Electromyographic Startle Response: Developmental Issues and Findings. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511499791.011
46. Balachandra, A., & Ruckmani, V. S. (2015). A Study on Emotional Intelligence, Family Environment, Mental Health Problems & Pro-Social Behavior. JOURNAL OF PSYCHOSOCIAL RESEARCH.
47. Balmer, H. C. (2014). Notfälle bei Demenz – was Sie tun können. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a000634
48. Banazak, D. A. (2000). Minor depression in primary care.. PubMed.
49. Banno, K., & Kryger, M. H. (2005). Sleep disorders in older people. Aging Health. https://doi.org/10.2217/1745509x.1.3.449
50. Barkin, R. L., Schwer, W. A., & Barkin, S. J. (2000). Recognition and Management of Depression in Primary Care. American Journal of Therapeutics. https://doi.org/10.1097/00045391-200007030-00008
51. Barnhill, J. W., Okuda, M., Simpson, H. B., Stein, D. J., Simpson, H. B., Phillips, K. A., Phillips, K. A., Mataix‐Cols, D., Cruz, L. F. D. L., & Stein, D. J. (2023). Obsessive-Compulsive and Related Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615375295.jb06
52. Barnovitz, M. A. L. C. M., & Joglekar, P. M. (2007). Medical Psychiatry: The Quick Reference.
53. Barré, M. (2013). Influence de la cognition sociale (Théorie de l'Esprit) sur la rémission fonctionnelle de la dépression et l'aptitude professionnelle.
54. Barth, F. (2021). Transitions, Eating Disorders, and Changing Selves: Interlocking Psychodynamics of Identity, Self, Life Changes, and Eating Disorders. Psychoanalytic Social Work. https://doi.org/10.1080/15228878.2020.1865172
55. Barton, J. J. S. (2022). Cerebral Visual Loss. Annals of Indian Academy of Neurology. https://doi.org/10.4103/aian.aian_136_22
56. Barton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J. (2014). Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review. Health Technology Assessment. https://doi.org/10.3310/hta18500
57. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
58. Battisti, O., & Dominé, F. (2010). [Inertia or overtreatment in children. When sleeping time is disturbed in infants: how to improve the family's distress].. PubMed.
59. Baum, R., & Campo, J. V. (2022). Medically Unexplained Symptoms. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396501
60. Baumeister, R. F., Vonasch, A., & Sjåstad, H. (2020). The Long Reach of Self-Control. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780197500941.003.0002
61. Beed, M., Sherman, R. A., & Mahajan, R. (2013). Neurology. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696277.003.0005
62. Beghi, E., Carpio, A., Forsgren, L., Hesdorffer, D. C., Malmgren, K., Sander, J. W., Tomson, T., & Hauser, W. A. (2009). Recommendation for a definition of acute symptomatic seizure. Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02285.x
63. Behrman, S., & Ebmeier, K. P. (2014). Can exercise prevent cognitive decline?. PubMed.
64. Bell, B. (2008). Depression and Parkinson’s Disease. touchREVIEWS in Neurology. https://doi.org/10.17925/usn.2008.04.01.67
65. Bello, Y. S. (2024). A Review on Sick Building Syndrome (SBS). Asian Journal of Science Technology Engineering and Art. https://doi.org/10.58578/ajstea.v3i1.4280
66. Berdina, O. B., Berdina, O. N., & Rychkova, L. (2017). SLEEP DISORDERS AND OBESITY IN ADOLESCENTS: PECULIARITIES OF PSYCHO-COGNITIVE STATUS (THE REVIEW OF LITERATURE). Acta Biomedica Scientifica (East Siberian Biomedical Journal). https://doi.org/10.12737/article_5a3a0e4a4bd9c6.35862127
67. Bereda, G. (2022). Stage and symptoms of bipolar disorders. Insights on the Depression and Anxiety. https://doi.org/10.29328/journal.ida.1001030
68. Beriguistain, A. (2019). La Realidad Virtual como Herramienta Terapéutica en Niños con TDAH. NeuroRehabNews. https://doi.org/10.37382/nrn.octubre.2019.575
69. Berliana, M. C., Razzaq, A., & Jannati, Z. (2023). Penerapan Konseling Individu Dengan Teknik Cognitive Restructuring Untuk Mengatasi Post Traumatic Stress Disorder. Journal of Society Counseling.. https://doi.org/10.59388/josc.v1i2.239
70. Bioulac, S. (2014). TDA/H et troubles du sommeil à l’âge adulte : revue de la littérature et particularités chronobiologiques. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.303
71. Bismuth, C., Bellec, L., Dally, S., & Lagier, G. (1980). [Benzodiazepine physical dependence. 6 cases (author's transl)].. PubMed.
72. Bitencourt, E. M., Kuerten, C. M. X., Budny, J., & Tuon, T. (2019). Doença de alzheimer: aspectos fisiopatológicos, qualidade de vida, estrategias terapêuticas da fisioterapia e biomedicina.. Inova Saúde. https://doi.org/10.18616/inova.v8i2.3573
73. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
74. Bjorvatn, B., Jernelöv, S., & Pallesen, S. (2021). Insomnia – A Heterogenic Disorder Often Comorbid With Psychological and Somatic Disorders and Diseases: A Narrative Review With Focus on Diagnostic and Treatment Challenges. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2021.639198
75. Blanco, A. P., López, M. L., Machado, I. C., González, M. V., Costa, X. C., Pérez, V. B., Spuch, C., & Lamas, F. O. (2019). Perfil neuropsicológico y sintomatología psicopatológica de pacientes con trastornos relacionados con sustancias a tratamiento en una unidad de día. African journal of rhetoric. https://doi.org/10.21134/haaj.v19i1.412
76. Blanco, C., & Bernardi, S. (2014). Gambling Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg62
77. Blumenthal, J. A., & Lett, H. S. (2005). Depression and Cardiac Risk. Journal of Cardiopulmonary Rehabilitation. https://doi.org/10.1097/00008483-200503000-00005
78. Bolten, M., & Légeret, C. (2021). Interface entre pédopsychiatrie et pédiatrie – illustré par le concept bâlois du traitement interdisciplinaire des troubles fonctionnels de la défécation. Paediatrica Métabolisme/maladies rares. https://doi.org/10.35190/f2021.2.1
79. Borelli, C. M., & Solari, H. (2019). Schizophrenia. JAMA. https://doi.org/10.1001/jama.2019.11073
80. Bouras, G., & Lazaratou, E. (2012). [Emergence of early childhood trauma in adult psychiatric symptomatology].. PubMed.
81. Boyd, J. P. (2004). Daytime Consequences of Sleep Apnea in REM and NREM Sleep. PsycEXTRA Dataset. https://doi.org/10.1037/e741622011-004
82. Boyle, J., Danjou, P., Alexander, R., Calder, N., Gargano, C., Agrawal, N., Fu, I., McCrea, J. B., & Murphy, M. G. (2008). Tolerability, pharmacokinetics and night‐time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2008.03331.x
83. Boyle, M., & Brown, T. M. (2002). ABC of psychological medicine: Delirium. BMJ. https://doi.org/10.1136/bmj.325.7365.644
84. Brennan, C. (2021). Learning Disabilities. https://doi.org/10.1002/9781119606987.ch11
85. Brewin, C. R. (2022). Identity – A critical but neglected construct in cognitive-behaviour therapy. Journal of Behavior Therapy and Experimental Psychiatry. https://doi.org/10.1016/j.jbtep.2022.101808
86. Brigham, C. R. (2003). Clinical Update: Grip Strength: An Uncommon Impairment. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2003.sepoct03
87. Brignole, M., Alboni, P., Benditt, D. G., Bergfeldt, L., Blanc, J., Thomsen, P. E. B., Dijk, J. G. V., Fitzpatrick, A., Hohnloser, S. H., Janousek, J., Kapoor, W. N., Kenny, R. A., Kułakowski, P., Masotti, G., Moyá, A., Raviele, A., Sutton, R., Theodorakis, G., Ungar, A., & Wieling, W. (2004). Guidelines on Management (diagnosis and treatment) of syncope ? update 2004. EP Europace. https://doi.org/10.1016/j.eupc.2004.08.008
88. Bromberger, J. T. (1998). Gender and Depression. https://doi.org/10.1093/oso/9780195113969.003.0003
89. Broniarczyk-Czarniak, M., Sowińska, K., Białas, J., & Talarowska, M. (2019). Ciężka depresja z nasilonymi zaburzeniami funkcji poznawczych czy otępienie.
90. Brook, S., Lee, J. J., & Daniel, C. (2009). What is the Role of Exercise and Movement?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199561070.003.0011
91. Brooks, C. N., Talmage, J. B., & Mueller, K. L. (2012). Subjective, Objective, or Both?. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2012.marapr02
92. Bruin, E. I. D., Meppelink, R., & Bögels, S. M. (2020). Mindfulness in attention deficit hyperactivity disorder. Routledge eBooks. https://doi.org/10.4324/9781315563862-7
93. BSc, P. L. G. R., & BSc, D. B. R. (2008). Glossary of Technical Terms. https://doi.org/10.1002/9781444302264.gloss
94. Budiman, M. W. (2002). MODULASI RESPONS IMUN PADA MENCIT BALB/c YANG STRES AKIBAT STRESOR SUARA.
95. Bujosa, C. M., & Monsalve, M. H. (2007). Caso Clínico "La esquizofrenia de inicio senil o cuando el reto de saber pseudodiagnosticar". Norte de Salud mental.
96. Burgoyne, K., Swartz, R., & Ananth, J. (1995). Porphyria: Reexamination of Psychiatric Implications. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000289001
97. Burkart, J., Jong, M. C., Ilenkyo, L., Verwer, C., Weber, S., Keller, T., & Klement, P. (2017). P172 Results of a randomised controlled trial with a homeopathic complex medicinal product in children with sleep disorders and restlessness. https://doi.org/10.1136/archdischild-2017-313273.260
98. Burns, A. (2000). Behavioral and Psychological Symptoms of Dementia and Caregiver Burden. International Psychogeriatrics. https://doi.org/10.1017/s1041610200007262
99. Büssing, A., Günther, A., Baumann, K., Frick, E., & Jacobs, C. (2013). Spiritual Dryness as a Measure of a Specific Spiritual Crisis in Catholic Priests: Associations with Symptoms of Burnout and Distress. Evidence-based Complementary and Alternative Medicine. https://doi.org/10.1155/2013/246797
100. Büyüktuncer, Z., & Isgin, K. (2017). Nutritional approach in premenstrual syndrome. Turkish Bulletin of Hygiene and Experimental Biology. https://doi.org/10.5505/turkhijyen.2017.46667
101. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
102. Cakmak, S. (2024). The Role of Physical Activity and Exercise in the Prevention and Treatment of Depression. International Journal of Computational and Experimental Science and Engineering. https://doi.org/10.22399/ijcesen.757
103. Campling, F., & Sharpe, M. (2008). Managing anxiety, panic, and depression. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199233168.003.0022
104. Campos, M. P. D. O., Hassan, B. J., Riechelmann, R. P., & Giglio, A. D. (2011). Cancer-related fatigue: a review. Revista da Associação Médica Brasileira (English Edition). https://doi.org/10.1016/s2255-4823(11)70046-7
105. Canapathy, M., Kurushev, J., Chitra, F., & Dash, M. (2019). Impact of Sensory Deprivation on Health Outcome. Acta Scientific Paediatrics. https://doi.org/10.31080/aspe.2019.02.0165
106. Canbulat, N., & Sonay, A. (2012). Pain Management and Nursing Approaches in Pediatric Oncology. InTech eBooks. https://doi.org/10.5772/32053
107. Canevini, M. P., Tassi, L., Fusco, L., Giallonardo, A. T., Guerrini, R., Mai, R., Rubboli, G., Tinuper, P., & Vigevano, F. (2002). Frontal lobe seizures. Epileptic Disorders.
108. Cao, F., Salem, H., Nagpal, C., & Teixeira, A. L. (2017). Prolonged delirium misdiagnosed as a mood disorder. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-57642016dn11-020014
109. Caplan, R., Bursch, B., & Leipzig, A. (2012). Somatization. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199843824.003.0079
110. Carlson, K. J., Eisenstat, S. A., & Ziporyn, T. (1997). The Women’s Concise Guide to Emotional Well-Being. https://doi.org/10.2307/j.ctv1r4xd2h
111. Casanova, Y. C., Torres, M. N., Ramírez, M. D. L., Ferrer, A. B., Calvo, R. N., & Ramos, I. J. (2021). Plan de cuidados de enfermería para paciente con deterioro de la movilidad.. Revista Sanitaria de Investigación.
112. Casper, R. C. (2022). Restlessness and an Increased Urge to Move (Drive for Activity) in Anorexia Nervosa May Strengthen Personal Motivation to Maintain Caloric Restriction and May Augment Body Awareness and Proprioception: A Lesson From Leptin Administration in Anorexia Nervosa. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2022.885274
113. Castro, S. S., & Araya, C. S. (2020). Anorexia nerviosa en adolescentes y adultos. Revista Ciencia y Salud Integrando conocimientos. https://doi.org/10.34192/cienciaysalud.v4i4.199
114. Chaijan, P. Y., Salehi, B., Khosrobeigi, A., Hajirahimi, M., Rafiei, M., & Ahmadi, H. T. (2014). Prevalence of Obsessive-Compulsive Disorder in Pediatric Patients with the Daytime Frequency Syndrome of Childhood or Pollakiuria. Journal of Arak University of Medical Sciences.
115. Chandra, D., Raj, K. S., & Prema (2018). Obstructive Sleep Apnea and Its Prosthodontic Management- An Overview. International Journal of Health Sciences and Research.
116. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
117. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
118. Charlton, S. R. (2020). Psychology and Black History Month in the United States. Eye on Psi Chi Magazine. https://doi.org/10.24839/2164-9812.eye24.4.18
119. Charmandari, E., Kino, T., Souvatzoglou, E., & Chrousos, G. P. (2003). Pediatric Stress: Hormonal Mediators and Human Development. Hormone Research in Paediatrics. https://doi.org/10.1159/000069325
120. Chaudhary, G., & Rashmi, M. (2022). ANXIETY DISORDERS. THE RESEARCH RESERVOIR. https://doi.org/10.47211/trr.2022.v08i02.019
121. Chauhan, R., Bhunal, S., Gupta, D., Kumar, R., & Sharma, T. (2020). TO STUDY CLINICAL PROFILE OF ACUTE CONFUSIONAL STATE IN A TERTIARY CARE HOSPITAL IN A HILLY AREA.. International Journal of Scientific Research. https://doi.org/10.36106/ijsr/0915904
122. Chaurasia, K., & Singh, B. (2017). A Comparative Study of Anxiety Level of Enuretic and Non-Enuretic Children. International Journal of Indian Psychology. https://doi.org/10.25215/0501.002
123. Chavan, R., Gosavi, M., Baviskar, M., & Goyal, N. P. (2023). Depression Detection using AI, ML and NLP. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-8886
124. Chen, Z., & Gong, Q. (2021). Resting-State Functional Connectivity in Unipolar Depression. Cambridge University Press eBooks. https://doi.org/10.1017/9781108623018.007
125. Chitra, F., Sunitha, V., Kurushev, J., & Dash, M. (2019). Sleeplessness and health. Insights on the Depression and Anxiety. https://doi.org/10.29328/journal.ida.1001010
126. Choi, S. J. (2007). Sleep Breathing Disorder. Tuberculosis & respiratory diseases. https://doi.org/10.4046/trd.2007.63.1.5
127. Chouliaras, L., Topiwala, A., Cristescu, T., & Ebmeier, K. P. (2015). Establishing the cause of memory loss in older people.. PubMed.
128. Chow, C. K., & Koren, G. (2015). Sedating drugs and breastfeeding.. PubMed.
129. Chu, B., Marwaha, K., Sanvictores, T., & Ayers, D. (2019). Physiology, Stress Reaction. StatPearls.
130. Chu, M. K. (2006). Pharmacologic Treatments of Insomnia. Journal of Korean Sleep Research Society. https://doi.org/10.13078/jksrs.06008
131. Chung, J.-K., & Kim, E.-J. (2011). Excessive Daytime Sleepiness Case Confounding with Thyrotoxicosis. Sleep Medicine and Psychophysiology. https://doi.org/10.14401/kasmed.2011.18.1.040
132. Cipriani, G., Danti, S., Picchi, L., Nuti, A., & Fiorino, M. D. (2020). Daily functioning and dementia. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-57642020dn14-020001
133. Clark, D. A., & Purdon, C. (2003). Cognitive theory and therapy of obsessions and compulsions. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139087094.006
134. Coca, A. (1994). Circadian rhythm and blood pressure control: physiological and pathophysiological factors.. PubMed.
135. Coghill, D., Bonnar, S., Duke, S. E., Graham, J., & Seth, S. G. (2009). Pre-school problems. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0006
136. Coghill, D., Bonnar, S., Duke, S., Graham, J., & Seth, S. (2009). Obsessive compulsive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0020
137. Cohen, A. S. A., & Gibson, W. T. (2019). EED-Related Overgrowth.
138. Coles, C. D. (2003). Individuals Affected by Fetal Alcohol Spectrum Disorder (FASD) and Their Families: Prevention, Intervention and Support.
139. Collu, A., Montaldo, S., Nonnoi, V., Campus, A., Pillai, G., Pinna, M., Primavera, D., & Carpiniello, B. (2007). Insomnia and excessive daytime sleepiness in psychotic patients taking traditional or atypical antipsychotic medications. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2007.01.527
140. Colán, T. C., Gálvez, G. A., & Zevallos, D. C. (2013). Síntomas psiquiátricos e insulinoma: reporte de caso Psychiatric symptoms and insulinoma: a case report.
141. Connolly, S. D., & Nanayakkara, S. (2010). Anxiety Disorders in Children: Common—But Often Missed.
142. Copeland‐Linder, N., Onigu-Otite, E., Serico, J. M., Jamora, M., & Belcher, H. M. E. (2017). Neurobiology of Child Maltreatment and Psychological Trauma. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0181
143. Corbett, J. J., & Brazis, P. W. (2007). The Eye and Headache. https://doi.org/10.1093/oso/9780195326567.003.0022
144. Coronado, H. D. G. (2022). Isolation: A Direct Attack on Society's Mental Health. Enletawa Journal. https://doi.org/10.19053/2011835x.14112
145. Coronado, L. M. Q., Florez, D. A. C., & Tarazona, M. C. L. (2017). Prevalencia depresión en estudiantes universitarios Bucaramanga 2017.
146. Corruble, E., Warot, D., & Soubrie, C. (2003). Insomnia linked to medications. SLEEP. https://doi.org/10.1007/978-1-4615-0217-3_20
147. Corrêa, C. R. G. L. (2013). Attention – Deficit Hyperactivity Disorder (ADHD) in Psychiatry and Psychoanalysis. InTech eBooks. https://doi.org/10.5772/52880
148. Cortés, M. D. C. M. (2013). Análisis evolutivo y valoración neuropsicológica integral de pacientes con deterioro cognitivo leve o enfermedad de Alzheimer..
149. Costa, G. (2012). [Stress of driving: general overview].. PubMed.
150. Costentin, J. (2015). La dopamine dans tous ses états.
151. Cotter, T. G., & Beresford, T. P. (2022). Treatment of Mental Health in Patients With Chronic Liver Disease. Clinical Liver Disease. https://doi.org/10.1002/cld.1200
152. Cox, D. J., Burket, R. C., Mikami, A. Y., Moore, M., & Merkel, R. L. (2007). ADHD and the Adolescent Driver.
153. Cox, R. C., Wright, K. P., Axelsson, J., & Balter, L. J. T. (2024). Diurnal variation in anxiety and activity is influenced by chronotype and probable anxiety-related disorder status. Psychiatry Research. https://doi.org/10.1016/j.psychres.2024.116006
154. Croci, I., Byrne, N. M., Choquette, S., Hills, A. P., Chachay, V., Clouston, A. D., O'Moore‐Sullivan, T., Macdonald, G. A., Prins, J. B., & Hickman, I. J. (2012). Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. Gut. https://doi.org/10.1136/gutjnl-2012-302789
155. Cruz, M. C. D., Camargo, R. P. D., Cruz, L. C. D., Schiefelbein, N., Cruz, D. M. D., & Cruz, M. C. C. D. (2020). Migrânea: revisão de literatura. ARCHIVES OF HEALTH INVESTIGATION. https://doi.org/10.21270/archi.v10i2.4670
156. Culpepper, L. (2015). Impact of Untreated Major Depressive Disorder on Cognition and Daily Function. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.13086tx4c
157. Cummings, J. L., & Zhong, K. (2017). Promise and Challenges in Drug Development and Assessment for Cognitive Enhancers. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214401.003.0001
158. Czajkowska‐Malinowska, M., & Cofta, S. (2014). Obturacyjny bezdech senny i jego społeczne następstwa.
159. Cáceres, F., Baca, G. H. R., Osorto, L. J. R., Godoy, K. J. Á., Hernández, G. R. O., Barahona, R. D. S., Sorto, N. D. Z., Suárez, M., Anduray, A. S. M., Mendoza, K. V. J., & Vargas, G. H. R. (2024). Síndrome Convulsivo. Religación Press eBooks. https://doi.org/10.46652/religacionpress.195.c296
160. Dahlem, M. A., Mair, T., & Müller, S. C. (2004). Spatio-Temporal Aspects of a Dynamical Disease: Waves of Spreading Depression. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7895-1_42
161. Dauwe, F., Imeraj, L., & Dhondt, K. (2017). [A young boy with periodic strange behavior and hypersomnia: Kleine-Levin syndrome].. PubMed.
162. Dehanov, S., & Ferreira, T. (2019). AN IMMACULATE CONCEPTION – THE DIFFERENTIAL DIAGNOSIS OF A DELUSION OF PREGNANCY. https://doi.org/10.26226/morressier.5d1a037857558b317a14085a
163. Dekkers, W. (2009). Persons with severe dementia and the notion of bodily autonomy*. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199554133.003.0027
164. Delcea, C. (2019). Orgasmic disorder in men. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.115
165. Delcea, C. (2019). Orgasmic disorder in women. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.11.122
166. Delcea, C. (2019). Sexual deviances. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.119
167. Derman, E., Whitesman, S., Dreyer, M., Patel, D., Nossel, C., & Schwellnus, M. (2010). Healthy lifestyle interventions in general practice: Part 12: Lifestyle and depression. South African Family Practice. https://doi.org/10.1080/20786204.2010.10873989
168. Derouesné, C. (2003). La plainte mnésique. Cliniques méditerranéennes. https://doi.org/10.3917/cm.067.0014
169. Desai, A., & Grossberg, G. T. (2022). Geriatric psychiatry. Pathy's Principles and Practice of Geriatric Medicine. https://doi.org/10.1002/9781119484288.ch72
170. Dessauer, M., Goetze, U., & lle, R. T. O. (1985). Periodic Sleep Deprivation in Drug-Refractory Depression. Neuropsychobiology. https://doi.org/10.1159/000118172
171. Deutsch, A. R., Vargas, M., Lucchini, M., Brink, L., Odendaal, H. J., & Elliott, A. (2022). Effect of individual or comorbid antenatal depression and anxiety on birth outcomes and moderation by maternal traumatic experiences and resilience. Journal of Affective Disorders Reports. https://doi.org/10.1016/j.jadr.2022.100365
172. Diler, R. S. (2003). Panic Disorder in Children and Adolescents. Yonsei Medical Journal. https://doi.org/10.3349/ymj.2003.44.1.174
173. DiLossi, J., & Harrison, M. (2023). The Relationship between Eating, Distress Tolerance, and Emotion Regulation in Obsessive-Compulsive Disorder. Cambridge University Press eBooks. https://doi.org/10.1017/9781009186865.014
174. DiLossi, J., & Harrison, M. (2023). Understanding Eating Disorders. Cambridge University Press eBooks. https://doi.org/10.1017/9781009186865.004
175. Dilsaver, S. C., Halle, M. H., & Medico, V. J. D. (1991). Symptoms of major depression: acute effect of withdrawing antidepressants. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1991.tb05531.x
176. DipHE, O. P. M. B., & PGCert, J. L. D. R. (2017). Mental health emergencies. https://doi.org/10.1002/9781119464365.ch7
177. Dodd, M. L. (2007). BASIC PRINCIPLES OF PSYCHIATRY. CRC Press eBooks. https://doi.org/10.1201/b14430-11
178. Dominé, F., Dadoumont, C., & Bourguignon, J. P. (2012). Eating Disorders throughout Female Adolescence. Endocrine development. https://doi.org/10.1159/000326697
179. Domínguez, M. R., Burgos, L. M., & Bergink, V. (2020). Perinatal Mood and Anxiety Disorders. Obstetrics and gynecology.. https://doi.org/10.1002/9781119450047.ch16
180. Domźał, T., Załeska, B., Kwasucki, J., & Gierczak-Walichnowska, J. (1980). [Diurnal rhythm of pain in sciatica. Preliminary report].. PubMed.
181. Douglas, M. E., Kim, B., Mayer, G., Crosby, B., & Towe-Goodm, N. (2012). Maternal Depression, Mothering and Child Development. InTech eBooks. https://doi.org/10.5772/38048
182. Drobizhev, М. Y., Galstyan, G. R., Surkova, E. V., Mel'nikova, O. G., & Divisenko, S. I. (2007). [Pain in diabetic neuropathy: psychosomatic aspects].. PubMed. https://doi.org/10.14341/probl200753643-47
183. Dube, S., & Babar, A. (2023). Stress and Insomnia – A Vicious Circle. Sustainability Agri Food and Environmental Research. https://doi.org/10.7770/safer-v13n2-art742
184. Duletic, N., Mijatovic-Papic, T., Cizmovic, B., & Kusturica, S. (2015). Differential Diagnostic Consideration of the Syndrome of Psychomotor Agitation in Geriatric Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31130-5
185. Dunsky, A. (2019). The Effect of Balance and Coordination Exercises on Quality of Life in Older Adults: A Mini-Review. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2019.00318
186. Dziegielewski, S. F. (2014). Quick References. https://doi.org/10.1002/9781394260577.bapp01
187. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
188. Ebenezer, I. S. (2015). Affective Disorders 2: Bipolar Disorder. https://doi.org/10.1002/9781118385777.ch7
189. Ebenezer, I. S. (2015). Sleep and Sleep Disorders. https://doi.org/10.1002/9781118385777.ch9
190. Edwards, J. G. (1995). Depression, antidepressants, and accidents. BMJ. https://doi.org/10.1136/bmj.311.7010.887
191. Efeoğlu, P., Dağlıoğlu, N., Hilal, A., & Gülmen, M. K. (2013). Drugs Used in Sexual Assaults: Features and Toxicological Investigations. DergiPark (Istanbul University).
192. Eichner, E. R. (1995). Overtraining: Consequences and prevention. Journal of Sports Sciences. https://doi.org/10.1080/02640419508732276
193. El-Radhi, A. S. (2015). Management of common behaviour and mental health problems. British Journal of Nursing. https://doi.org/10.12968/bjon.2015.24.11.586
194. Elbert, T., Schauer, M., & Neuner, F. (2004). Memory of Traumatic Stress. Klinische Neurophysiologie. https://doi.org/10.1055/s-2004-831963
195. Eldeib, S., Damodaran, J., Wahba, A. A., Khayal, A., Attia, M. F., Elbermeshty, A., Khalloof, A., & Mousa, H. (2023). None. International Journal of Clinical Studies and Medical Case Reports. https://doi.org/10.46998/ijcmcr.26.5
196. Erstad, B. L., & Cotugno, C. L. (1995). Management of alcohol withdrawal. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/52.7.697
197. Escande, M., & Boucard, J. (1999). [Atypical depression].. PubMed.
198. Eskander, F. S. L., Hakim, K. Y. K., Ibrahim, D., & ElMallah, W. (2021). Incidence Of Post-Operative Delirium In Geriatric Patients Undergoing Hip Replacement Surgery Using Pre-Operative Haloperidol. QJM. https://doi.org/10.1093/qjmed/hcab086.109
199. Espinar, J. B. (1998). Trastornos del alertamiento y parasomnias de la transición vigilia-sueño. Revista de Neurología. https://doi.org/10.33588/rn.26151.981053
200. Esquiliano, G. R., Ramírez, I. M., Valdés, A. T., & Aguilar, C. A. T. (2004). Daño neurológico secundario a hipoxia isquemia perinatal. Archivos de neurociencias (México, D.F.).
201. Estraneo, A., Masotta, O., Bartolo, M., Pistoia, F., Perin, C., Marino, S., Lucca, L. F., Pingue, V., Casanova, E., Romoli, A. M., Gentile, S., Formisano, R., GP, S., Scarponi, F., Tanti, D., Bongioanni, P., Rossato, E., Santangelo, A., AR, D., ... Bellis, D. (2020). Multi-center study on overall clinical complexity of patients with prolonged disorders of consciousness of different etiologies. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.6198847
202. Estraneo, A., Masotta, O., Bartolo, M., Pistoia, F., Perin, C., Marino, S., Lucca, L. F., Pingue, V., Casanova, E., Romoli, A. M., Gentile, S., Formisano, R., GP, S., Scarponi, F., Tanti, D., Bongioanni, P., Rossato, E., Santangelo, A., AR, D., ... Bellis, D. (2020). Multi-center study on overall clinical complexity of patients with prolonged disorders of consciousness of different etiologies. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.6198848
203. Evans, J. R., Velsor, P. V., & Schumacher, J. E. (2002). Addressing Adolescent Depression: A Role for School Counselors.. Professional School Counseling.
204. Evers, M. M., & Marin, D. B. (2002). Mood disorders. Effective management of major depressive disorder in the geriatric patient.. PubMed.
205. Fabbian, F., Smolensky, M. H., Tiseo, R., Pala, M., Manfredini, R., & Portaluppi, F. (2012). Dipper and Non-Dipper Blood Pressure 24-Hour Patterns: Circadian Rhythm–Dependent Physiologic and Pathophysiologic Mechanisms. Chronobiology International. https://doi.org/10.3109/07420528.2012.715872
206. Fahn, S., Greene, P., Ford, B., & Bressman, S. (2003). Movement Disorders. https://doi.org/10.1007/978-1-4757-4552-8_9
207. Fahn, S., Greene, P., Ford, B., Bressman, S., & Frucht, S. J. (2009). Movement Disorders. https://doi.org/10.1007/978-1-57340-359-7_9
208. Falk, A., Joseph, R., Smith, S., & Wilk, A. (2023). Mood and Anxiety Disorders: Major Depressive Disorder.. PubMed.
209. Falk, M. J., & Moreno, M. A. (2019). What Parents Need to Know About Genetic Testing. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2019.0005
210. Falloon, K., Arroll, B., & Fernando, A. (2008). Sleep disorder (insomnia). BMJ. https://doi.org/10.1136/bmj.a1245
211. Fama, J. M., & Wilhelm, S. (2010). Obsessions. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0616
212. Farne, H., Norris-Cervetto, E., & Warbrick‐Smith, J. (2015). Limb weakness. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198716228.003.0032
213. Fennell, T. B. A. M. J. V. (2008). Mindfulness-Based Cognitive Therapy: preventing relapse in depression. https://doi.org/10.4324/9780203884683-8
214. Fiar, Z., Hroudov, J., & Raboch, J. (2012). Neurotransmission in Mood Disorders. InTech eBooks. https://doi.org/10.5772/31831
215. Filipenka, H. (2021). Major depressive disorder..
216. Fink, M. (2010). Depressive Mood Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0009
217. Fink, M. (2010). Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0011
218. Fitzgerald, C., & Patten, S. B. (2008). Is Multiple Sclerosis Patient Depressed, Stressed, or Both? How to Sort through Overlapping Symptoms and Provide Appropriate Treatment. Current psychiatry.
219. Flaer, P. J. (2015). Co-Morbidity of Obsessive-Compulsive Disorder (OCD) and Chronic Depression. Clinical and Experimental Medical Letters.
220. Flaer, P. J., & AlRubaie, M. (2019). Cannabidiol (CBD): An Innovative Pharmacological Treatment for Obsessive Compulsive Disorder (OCD). https://doi.org/10.37591/rrjon.v7i1.965
221. Fonseca, R. S. D., Nazaré, G. O. D., Silva, P. S. L. D., Fortes, G. N., & Lemos, A. L. (2017). SINTOMAS DEPRESSIVOS EM ACADÊMICOS DE UMA UNIVERSIDADE PÚBLICA NO OESTE DO ESTADO DO PARÁ, RELATO DE EXPERIÊNCIA. 13º Congresso Internacional Rede Unida.
222. Frean, J., Jong, G. D., & Albrecht, R. (2008). Imaginary bugs, real distress: delusional parasitosis.. PubMed.
223. Fundić, I. (2017). Ovisnost u obitelji i utjecaj na razvoj djeteta.
224. Gabbaï, P. (2004). Longévité et avance en âge. Gérontologie et société.
225. Garay, M. A., Richards, S., Mj, M. U., & Luguercho, C. (2007). [Psychotic major depressive episode: target symptoms in males and females].. PubMed.
226. García, M. D. S., & Calderón, R. M. (2010). Síntomas no motores en la enfermedad de Parkinson y estimulación cerebral profunda. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009745
227. García, R. G., Alvarez, M. R., & Arturo, F. (2010). Cefalea por uso excesivo de medicamentos: implicaciones clínicas y terapéuticas Medication over use headache: clinical and therapeutic implications.
228. Garrabé, J., & Cousin, F. (2012). Acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0081
229. Gaynor, A. M., Hartley, H., & Sands, S. A. (2020). Physical and Cognitive Rehabilitation for Children with Brain and Spinal Tumors. CRC Press eBooks. https://doi.org/10.1201/9781003090120-8
230. Ghaisani, N. (2018). Potensi Ketamin Dosis Rendah untuk Penderita Depresi Berat. JIMKI Jurnal Ilmiah Mahasiswa Kedokteran Indonesia.
231. Ghika, J., Diéguez, S., Assal, F., & Démonet, J. (2013). [Mirror behaviors in dementia: the many mirror signs].. PubMed.
232. Gilg, T. (2012). Psychophysische Leistungsminderungen und Fahrsicherheit, alkoholbedingte Fahruntuechtigkeit bzw. Fahrunsicherheit.
233. Giorelli, A. S., Santos, P. P. D., Carnaval, T., & Gomes, M. D. M. (2012). Sonolência excessiva diurna: aspectos clínicos, diagnósticos e terapêuticos Excessive daytime sleepiness: clinical, diagnostic and therapeutic aspects.
234. Giri, M. A., Bhalke, R. D., Lodha, Y., Pawar, K. I., Kulkarni, Y. A., & Bhalke, R. D. (2022). None. International Journal of Pharmaceutical Sciences and Research. https://doi.org/10.13040/ijpsr.0975-8232.13(2).559-68
235. Giusti, V., & Panchaud, M. (2007). [Psychological profile of obese patients].. PubMed.
236. Glasgow, H. B., Burkholder, J. M., Schmechel, D. E., Tester, P. A., & Rublee, P. A. (1995). Insidious effects of a toxic estuarine dinoflagellate on fish survival and human health. Journal of Toxicology and Environmental Health. https://doi.org/10.1080/15287399509532051
237. Gleason, M. M., & Thompson, L. A. (2022). Depression and Anxiety Disorder in Children and Adolescents. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2022.0052
238. Goldberg, S., & Chapman, J. (2014). Practice question. Nursing Older People. https://doi.org/10.7748/nop.26.10.14.s18
239. Gong, M., Tang, Q., Tan, S., & Hu, X. (2024). [Research Progress in the Effect of Exercise Intervention on Sleep Disorders and the Mechanisms Involved].. PubMed. https://doi.org/10.12182/20240160404
240. González, M. F. A. (2019). DETERMINACIÓN DE LOS EFECTOS FISIOLÓGICOS CAUSADOS POR ESTRÉS ACADÉMICO Y LABORAL EN ESTUDIANTES DE QUÍMICA Y QUÍMICO FARMACÉUTICO BIOLÓGO.
241. Goodyer, I., Herbert, J., Tamplin, A. K., & Altham, P. M. E. (2000). Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.177.6.499
242. Gordon, M. F., & Leder, A. (2012). Serotonin Syndrome. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-835-5_18
243. Gordon, M. L., Doghramji, P. P., & Lieberman, J. A. (2007). Stay Awake! Understanding, Diagnosing, and Successfully Managing Narcolepsy. Current psychiatry.
244. Gordon, M., & Melvin, G. (2014). Prescribing for depressed adolescents: Office decision-making in the face of limited research evidence. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.12517
245. Gortani, G. (2022). Approccio pratico al bambino “sempre stanco”. Medico e Bambino. https://doi.org/10.53126/meb41168
246. Gottlieb, S., & Friedman, S. B. (1991). Conduct Disorders in Children and Adolescents. Pediatrics in Review. https://doi.org/10.1542/pir.12.7.218
247. Green, N., Gaydos, S., Ewan, H., & Nicol, E. (2019). Fatigue and countermeasures. CRC Press eBooks. https://doi.org/10.1201/9780429021657-33
248. Grigorenko, E. L., Klin, A., & Volkmar, F. R. (2003). Annotation: Hyperlexia: disability or superability?. Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/1469-7610.00193
249. Group, M. T., Mackway‐Jones, K., Marsden, J., & Windle, J. (2006). Discriminator Dictionary. https://doi.org/10.1002/9780470757321.oth3
250. Guandique, R. Y., & Vásquez, C. Y. P. (2009). Factores de riesgo que provocan estrés laboral en los docentes universitarios.
251. Guernsey, E., & Glenn, O. A. (2023). Patient-Friendly Summary of the ACR Appropriateness Criteria®: Ataxia-Child. Journal of the American College of Radiology. https://doi.org/10.1016/j.jacr.2022.12.010
252. Gupta, K., & Mamidi, P. (2018). Deva grahonmada: Interictal behavior syndrome of temporal lobe epilepsy?/obsessive-compulsive disorder with mania?. International Journal of Yoga - Philosophy Psychology and Parapsychology. https://doi.org/10.4103/ijny.ijoyppp_24_17
253. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
254. Guszkowska, M. (2013). [Exercise dependence--symptoms and mechanisms].. PubMed.
255. Guthrie, M., Zubatsky, M., & Smith, C. W. (2015). Family Stress and Counseling. Family Medicine. https://doi.org/10.1007/978-1-4939-0779-3_30-1
256. Gutiérrez-Achury, A. M., Vanegas-Vidal, M., Salazar-Díaz, L. I., & Arías, G. M. A. (2009). Factores farmacológicos y no farmacológicos que afectan la adherencia al tratamiento de los pacientes esquizofrénicos dados de alta en la Unidad de Salud Mental del Hospital Universitario de Neiva entre enero y junio del 2008. RFS Revista Facultad de Salud. https://doi.org/10.25054/rfs.v1i2.43
257. Guzzetti, J. R., & Banks, S. (2022). Dynamics of recovery sleep from chronic sleep restriction. SLEEP Advances. https://doi.org/10.1093/sleepadvances/zpac044
258. Göbel, H., Heinze, A., Dworschak, M., Heinze‐Kuhn, K., & Stolze, H. (2000). Placebokontrollierte, randomisierte und doppelblinde Studien zur Analyse der Wirksamkeit und Verträglichkeit von Oleum-menthae-piperitae-Lösung LI170 bei Kopfschmerz vom Spannungstyp und Migräne. Steinkopff eBooks. https://doi.org/10.1007/978-3-642-57735-2_12
259. Ha, J. S. (2019). Depression in the Elderly and the Resources of Practical Theology. The Gospel and Praxis. https://doi.org/10.25309/kept.2019.8.15.232
260. Hadi, I., Wijayati, F., Usman, R. D., & Rosyanti, L. (2017). Major Depressive Disorder: A Mini Review. Health Information Jurnal Penelitian. https://doi.org/10.36990/hijp.v9i1.102
261. Hainline, B., Gurin, L., & Torres, D. M. (2019). Managing Expectations Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0011
262. Hall, A., Farooq, T. B., & Alcaraz, R. (2022). Hypocalcemia-Induced Reversible Psychosis. Cureus. https://doi.org/10.7759/cureus.20874
263. Hamed, S. A. (2014). Diabetes mellitus and the brain : special emphasis on cognitive function : review. The South African journal of diabetes & vascular disease.
264. Han, K., & Jung, S.-W. (2025). Functional medicine approaches to energy metabolism: chronic fatigue syndrome, brain-gut axis and weight control. Korean Institute for Functional Medicine. https://doi.org/10.32581/jkifm.2025.8.1.103
265. Hao, Y., Controzzi, M., Cipriani, C., Popović, D. B., Yang, X., Chen, W., Zheng, X., & Carrozza, M. C. (2013). Controlling hand-assistive devices: utilizing electrooculography as a substitute for vision. IEEE Robotics & Automation Magazine. https://doi.org/10.1109/mra.2012.2229949
266. Harvey, A. G., & Tang, N. K. Y. (2011). (Mis)perception of sleep in insomnia: A puzzle and a resolution.. Psychological Bulletin. https://doi.org/10.1037/a0025730
267. Hasanat, N. U., & Ma, S. (2015). Pengembangan Modul untuk Meningkatkan Emosi Positif Pasien di Rumah Sakit. Buletin Psikologi. https://doi.org/10.22146/bpsi.7446
268. Hassan, M. S., Sidow, N. O., & Mohamed, N. A. (2022). Transient global amnesia: Uncommon diagnosis of exclusion. Clinical Case Reports. https://doi.org/10.1002/ccr3.6533
269. Hatcher-Kay, C., & King, C. A. (2003). Depression and Suicide. Pediatrics in Review. https://doi.org/10.1542/pir.24-11-363
270. Hatcher-Kay, C., & King, C. A. (2003). Depression and Suicide. Pediatrics in Review. https://doi.org/10.1542/pir.24.11.363
271. Hawes, D. J., & Scalise, P. (2005). Childhood depression: early risk and resilience and introducing solids to infants. https://doi.org/10.4225/50/5552facc15227
272. Heilbroner, P. L., & Castaneda, G. Y. (2007). Pediatric neurology : essentials for general practice. Lippincott Williams & Wilkins eBooks.
273. Henkin, R. I., & Abdelmeguid, M. (2020). Smell Loss and Onset of Phantosmia are Critical Aspects of Head Injury Cognition. The FASEB Journal. https://doi.org/10.1096/fasebj.2020.34.s1.02320
274. Henríquez, M. R., Gómez, A. H., Balut, F., Hernández, V., & Perfetti, A. J. (2023). Trastorno de sueño inquieto: una nueva entidad clínica a considerar en niños. Andes pediatrica. https://doi.org/10.32641/andespediatr.v94i1.4203
275. Herman, H., Ardani, I. G. A. I., Aryani, L. N. A., Windiani, I. G. A. T., Adnyana, I. G. N. S., & Setiawati, Y. (2022). Signs and symptoms of depression in children and adolescents with type 1 diabetes mellitus. International journal of health & medical sciences. https://doi.org/10.21744/ijhms.v5n1.1861
276. Hillman, D. R., Carlucci, M., Charchaflieh, J., Cloward, T. V., Gali, B., Gay, P. C., Lyons, M. M., McNeill, M. M., Singh, M., Yılmaz, M., & Auckley, D. (2023). Society of Anesthesia and Sleep Medicine Position Paper on Patient Sleep During Hospitalization. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000006395
277. Hindmarch, I. (1998). The behavioural toxicity of antidepressants. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199807006-00002
278. Holovanova, A., Kyrychek, L., Yermolenko, T., & Hladkykh, F. (2017). Pharmacotherapeutic Effect of Stress Protectors in the Age Aspect. Path of Science. https://doi.org/10.22178/pos.29-6
279. Holtzheimer, P. E., & Hamani, C. (2014). Deep brain stimulation for treatment-resistant depression. https://doi.org/10.2217/ebo.13.577
280. Hong, C. (2013). 분과 심포지움 2. 임상 : 새로운 진단체계 DSM-5; 조현병 스펙트럼 및 기타 정신병적 장애,성격장애. 한국심리학회 연차 학술발표논문집.
281. Horn, J. B., Zandbergen, E., Koelman, J., & Hijdra, A. (2008). Prognosis for patients in a coma following cardiopulmonary resuscitation.
282. Howland, R. H. (2010). Rapid Eye Movement Sleep. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1049
283. Hsieh, M. T., Peng, W., Wu, C., Ng, K., Cheng, C. Y., & Xu, H. (2010). None. Planta Medica. https://doi.org/10.1055/s-002-20741
284. Huprich, S. K. (2010). Schizoid Personality Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0819
285. Huron, C. (2017). Developmental Coordination Disorder. The SAGE Encyclopedia of Abnormal and Clinical Psychology. https://doi.org/10.4135/9781483365817.n425
286. Hȧrd, E., Archer, T., & Hansen, S. (2003). Animal Models of Mental Retardation. Humana Press eBooks. https://doi.org/10.1385/0-89603-177-2:273
287. Ingrassia, G. F. (2012). HISTORICAL EVOLUTION OF MEDICAL KNOWLEDGE IN THE FIELD OF VEGETATIVE STATE.
288. Iroku-Malize, T., & Grissom, M. (2019). Violence and Public and Personal Health: Sexual Violence, Sexual Assault, and Sex Trafficking.. PubMed.
289. Irom, B. S. (2020). Is Mental Health Condition a Cause of Anxiety. Journal of Traumatic Stress Disorders & Treatment. https://doi.org/10.37532/2324-8947.2020.9(6).217
290. Issa, B. A. (2013). Prevalence and Correlates of Depressive Disorders among People Living with HIV/AIDS, in North Central Nigeria. Journal of AIDS & Clinical Research. https://doi.org/10.4172/2155-6113.1000251
291. Izquierdo, A. Y. (2005). Crisis convulsivas. Concepto, clasificación y etiología. Emergencias: Revista de la Sociedad Española de Medicina de Urgencias y Emergencias.
292. Jaffee, M. S., Broshek, D. K., & Svingos, A. M. (2023). What Is a Concussion?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190630119.003.0001
293. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
294. Jak, H. J. O. A. J., ColÃ, A. M. G. C. C., Drummond, D. M. S. S. P., & Twamley, J. B. L. E. W. (2015). Sleep Disturbance, Psychiatric, and Cognitive Functioning in Veterans with Mild to Moderate Traumatic Brain Injury. Journal of Sleep Disorders Treatment & Care. https://doi.org/10.4172/2325-9639.1000153
295. Jaramillo, A., González‐Hernández, A., Santos, J. B., & Leaver, E. (2021). Programa de Estimulación Sensorial Visual y auditivo para personas con deterioro cognitivo Leve. Erasmus Semilleros de Investigación. https://doi.org/10.25054/2590759x.3449
296. Jenkins, J. M., & Oatley, K. (1998). The Development of Emotion Schemas in Children: Processes That Underlie Psychopathology. https://doi.org/10.1093/oso/9780195093216.003.0003
297. Jimenez, B., & Lechuga, Y. A. (2019). La importancia del sueño en la vida cotidiana.
298. Jiménez, M. Á. P., Fernández, M. G., Santiago, M. D. M., & Castillo, M. C. F. D. (2012). Diagnóstico videoelectroencefalográfico de los episodios paroxísticos epilépticos y no epilépticos en el lactante y el niño en edad preescolar. Revista de Neurología. https://doi.org/10.33588/rn.54s03.2012240
299. Jovanović, J., Lazaridis, K., & Stefanović, V. (2006). THEORETICAL APPROACHES TO PROBLEM OF OCCUPATIONAL STRESS. Acta Facultatis Medicae Naissensis.
300. Judd, L. L., Schettler, P. J., Brown, E. S., Wolkowitz, O. M., Sternberg, E. M., Bender, B. G., Bulloch, K., Cidlowski, J. A., Kloet, E. R. D., Fardet, L., Joëls, M., Leung, D. Y., McEwen, B. S., Roozendaal, B., Rossum, E. F. C. V., Ahn, J., Brown, D. W., Plitt, A., & Singh, G. (2014). Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2014.13091264
301. Juruena, M. F. (2009). Exposição ao chumbo: consequências neuropsiquiátricas e comportamentais. Medicina (Ribeirão Preto). https://doi.org/10.11606/issn.2176-7262.v42i3p296-300
302. Kanchanatawan, B., & Kasantikul, D. (2007). Antipsychotic-induced tardive movement disorders: a series of twelve cases.. PubMed.
303. Kandratavicius, L., Hallak, J., & Leite, J. P. (2007). Psicose e depressão na epilepsia do lobo temporal. Journal of Epilepsy and Clinical Neurophysiology. https://doi.org/10.1590/s1676-26492007000400004
304. Kang, E. K., & Kim, S. S. (2020). Behavioral insomnia in infants and young children. Clinical and Experimental Pediatrics. https://doi.org/10.3345/cep.2020.00052
305. Kanner, A. M., & Dunn, D. W. (2004). Diagnosis and Management of Depression and Psychosis in Children and Adolescents With Epilepsy. Journal of Child Neurology. https://doi.org/10.1177/088307380401900108
306. Kantharia, S. J., Sn, G., & Patel, K. B. (2022). Age Related Neurodegenerative Disorders w.s.r to Dementia. International Journal of Ayurveda and Pharma Research. https://doi.org/10.47070/ijapr.v10i6.2367
307. Kanyengo, C. W. (2009). Zambia: The challenge of informing blind and deaf clients.
308. Kaplan, E. M. (1997). Antidepressant noncompliance as a factor in the discontinuation syndrome.. PubMed.
309. Kaplan, H., Sadock, B. J., & Cancro, R. (1991). Comprehensive Textbook of Psychiatry/V.. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-114-9-823_8
310. Karimzadeh, P. (2012). Psycho-cognitive behavioral problems in sleep disordered children.. PubMed. https://doi.org/10.3969/j.issn.1673-5374.2012.08.012
311. Karki, M., & Mahara, G. (2022). Heart Diseases, Anxiety Disorders, and Negative Thoughts. Heart and Mind. https://doi.org/10.4103/hm.hm_45_21
312. Karssemeijer, E. G., Heijden, C. D. V. D., Wolters, T. L. C., Boekhorst, B. T., Avest, M. T., & Kramers, C. (2021). [Don't stop medication too abruptly: advice about the discontinuation of medication]..
313. Karssemeijer, E. G., Heijden, C. D. V. D., Wolters, T. L. C., Boekhorst, B. T., Avest, M. T., & Kramers, C. (2021). [Don't stop medication too abruptly: advice about the discontinuation of medication].. PubMed.
314. Kasper, S. (2006). Anxiety disorders: under-diagnosed and insufficiently treated. International Journal of Psychiatry in Clinical Practice. https://doi.org/10.1080/13651500600552297
315. Kassinove, H., & Broll-Barone, B. (2012). Self-reported anger episodes in Romanian children, adolescents, and adults.
316. Kazymova, N., Kharlamenkova, N. Y., & Nikitina, D. A. (2019). Severe life events and their psychological consequences: loss or threat of loss of nearest. Vestnik Kostroma State University Series Pedagogy Psychology Sociokinetics. https://doi.org/10.34216/2073-1426-2019-25-2-96-101
317. Keegan, L. (2003). Alternative and Complementary Modalities for Managing Stress and Anxiety. Critical Care Nurse. https://doi.org/10.4037/ccn2003.23.3.55
318. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
319. Kelly, P. (2012). Posttraumatic Stress Disorder. Pediatrics in Review. https://doi.org/10.1542/pir.33.8.382
320. Kemp, B., Bongartz, K., & Rath, W. (2003). Postpartale psychische Störungen - ein unterschätztes Problem in der Geburtshilfe. Zeitschrift für Geburtshilfe und Neonatologie. https://doi.org/10.1055/s-2003-43419
321. Kennedy, J. E., Jaffee, M. S., & Cooper, D. (2013). Posttraumatic Stress Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da08
322. Kennedy, S. H. (2008). Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2008.10.3/shkennedy
323. Kezele, M. (2019). Djeca s ADHD-om u primarnom obrazovanju.
324. Khabibullin, A. B. (2023). Signs of fatigue and fatigue, their causes and prevention. Scientific and educational basics in physical culture and sports. https://doi.org/10.57006/2782-3245-2023-10-2-24-27
325. Khandelwal, S., & Desai, M. (2024). Prevalence of Fatigue Among Female Academicians. International Journal of Health Sciences and Research. https://doi.org/10.52403/ijhsr.20240324
326. Kholik, M. (2013). TERAPI RELAKSASI OTOT PROGRESIF PADA PENDERITA GENERALIZED ANXIETY DISORDER ( GAD.
327. Kim, G.-M., Jeong, W., & Hwang, T. (2019). Depression and Gap between Perceived- and Self-Willingness-to-Pay for Labor in Community-Dwelling Full-Time Female Homemakers. Journal of Korean Neuropsychiatric Association. https://doi.org/10.4306/jknpa.2019.58.4.322
328. Kirakosyan, G. (2022). Understanding psychosis: diagnosis and clinical presentation (updates for clinicians). World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2022.13.1.0759
329. Knapen, J., Vancampfort, D., Schoubs, B., Probst, M.-T., Sienaert, P., Haake, P., Peuskens, J., & Pieters, G. (2009). Exercise for the Treatment of Depression. The Open Complementary Medicine Journal. https://doi.org/10.2174/1876391x00901010078
330. Koo, S. K. (2018). Depression Status in Korea. Osong Public Health and Research Perspectives. https://doi.org/10.24171/j.phrp.2018.9.4.01
331. Korepina, O. S., Gnezditskii, V. V., Revenok, E. V., Polianskiĭ, V. B., & Kalashnikova, L. A. (1998). [Evoked potentials in assessing the sensory, activating and cognitive functions of the normal human brain and in cortical and subcortical types of vascular dementia].. PubMed.
332. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
333. Krigger, K., McNeely, J. D., & Lippmann, S. (1997). Dying, death, and grief. Postgraduate Medicine. https://doi.org/10.3810/pgm.1997.03.187
334. Krolak‐Salmon, P., & Thomas-Antérion, C. (2010). Fonctions exécutives, attention et mémoire de travail au cours du vieillissement. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2010.0072
335. Krolak‐Salmon, P., & Thomas-Antérion, C. (2010). Fonctions exécutives, attention et mémoire de travail au cours du vieillissement. Revue de neuropsychologie. https://doi.org/10.3917/rne.025.0003
336. Kumar, A. (2019). None. Current Trends On Biotechnology & Microbiology Open Access Publishers. https://doi.org/10.32474/ctbm.1.2
337. Kumar, D., Jagannathan, A., & Sivakumar, T. (2023). I paint, I sing, I dance; I also have a mental illness: The importance of personally meaningful leisure activities in recovery from severe mental illness. Indian Journal of Psychiatry. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_218_23
338. Kumar, G. P., Krishna, P. Y., Manisha, D., Singh, G., Khushboo, A., & Ps, M. (2015). ROLE OF MANAS BHAVA IN THE ETIOPATHOGENESIS OF AMLAPITTA IN CONTEXT OF HYPERACIDITY.
339. Kučikienė, O., Lesauskaitė, V., Macijauskienė, J., Vainoras, A., Blaževičienė, A., Samėnienė, J., Alekna, V., Satkunskienė, D., Naudžiūnas, A., & Krutulytė, G. (2009). Dažniausi hospitalizuotų pagyvenusio amžiaus pacientų sveikatos sutrikimai.
340. Lam, R. W. (2012). Clinical features and diagnosis. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199692736.003.0004
341. Lampe, E. W., Presseller, E. K., Abber, S. R., Sonnenblick, R. M., Juarascio, A. S., & Manasse, S. M. (2023). Affective profiles of exercise episodes are associated with maladaptive and adaptive motivations for exercise. European Eating Disorders Review. https://doi.org/10.1002/erv.3012
342. Landers, D. M. (2002). Anorexia in Exercise and Sport. Medicine & Science in Sports & Exercise. https://doi.org/10.1097/00005768-200205001-01795
343. Lansky, M. R. (1989). The Explanation of Impulsive Action. British Journal of Psychotherapy. https://doi.org/10.1111/j.1752-0118.1989.tb01259.x
344. Latta, F., & Cauter, E. V. (2003). Sleep and Biological Clocks. Handbook of Psychology. https://doi.org/10.1002/0471264385.wei0313
345. Lawrie, S. M. (2010). Schizophrenia, bipolar disorder, obsessive–compulsive disorder, and personality disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260507
346. Lawson, W., & Dombroski, B. A. (2017). Problems with Object Permanence: Rethinking Traditional Beliefs Associated with Poor Theory of Mind in Autism. Journal of Intellectual Disability - Diagnosis and Treatment. https://doi.org/10.6000/2292-2598.2017.05.01.1
347. Ledezma, C., Soto, K., & Suárez, M. I. (2015). Depresión en el adulto mayor en Costa Rica: un problema social. Revista Hispanoamericana de Ciencias de la Salud.
348. Lee, E., Cheuk, J. T. Y., & Ungvári, G. S. (2009). A Patient with Chronic Schizophrenia Presenting with Multiple Deliberate Self-Harm and Genital Self-Mutilation. Hong Kong journal of psychiatry.
349. Lee, J., Brook, S., & Daniel, C. (2009). Nights are the Worst Time. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199561070.003.0017
350. Lee, S. G., & Kim, Y. R. (2015). Effect of Dual Task Training in Visual Control and Unstable Base on the Gait of Stroke Patient. Journal of international academy of physical therapy research. https://doi.org/10.5854/jiaptr.2015.03.31.788
351. Lee, Y. L., Wong, J., & Ng, S. Y. (2022). Delirium in patients following general anaesthesia. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.202228
352. Lehman, T. J. A. (2004). The Child Who Hurts All Over. https://doi.org/10.1093/oso/9780195157284.003.0004
353. Leiblum, S. R. (2003). Arousal disorders in women: complaints and complexities. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2003.tb05392.x
354. Leitzelar, B. N., & Koltyn, K. F. (2021). Exercise and Neuropathic Pain: A General Overview of Preclinical and Clinical Research. Sports Medicine - Open. https://doi.org/10.1186/s40798-021-00307-9
355. Leoni, M. C., Pizzo, D., Rundo, B., Tasso, G., & Marchi, A. (2009). Atassia in ex-prematuro: un caso pediatrico. Bollettino della Società Medico Chirurgica di Pavia. https://doi.org/10.6092/2039-1404.122.404
356. Leung, M., Thompson, B., Black, J., Dai, S., & Alsweiler, J. M. (2017). The effects of preterm birth on visual development. Clinical and Experimental Optometry. https://doi.org/10.1111/cxo.12578
357. Leu‐Semenescu, S., & Arnulf, I. (2010). [Disruptive nocturnal behavior in elderly subjects: could it be a parasomnia?].. PubMed. https://doi.org/10.1684/pnv.2010.0210
358. Levani, Y., Prastya, A. D., & Ramadhani, S. N. (2019). KLEPTOMANIA: MANIFESTASI KLINIS DAN PILIHAN TERAPI. MAGNA MEDICA Berkala Ilmiah Kedokteran dan Kesehatan. https://doi.org/10.26714/magnamed.6.1.2019.31-37
359. Lewis, B. (2012). Melancholia in the Subjunctive Mood. Tikkun. https://doi.org/10.1215/08879982-2012-2022
360. León, M. S. M. D. (2017). Trastorno por déficit de atención con hiperactividad: autorregulación emocional y funciones ejecutivas.
361. Lečić-Toševski, D. M., Pejović-Milovančević, M., Popović-Deušić, S., & Šušić (2007). [Psychiatric aspects of sleep].. PubMed.
362. Li, X., & Li, S. X. (2022). Paediatric Insomnia. https://doi.org/10.1007/978-981-19-5791-8_6
363. Lichter‐Konecki, U., Caldovic, L., Morizono, H., & Simpson, K. (2011). Ornithine transcarbamylase deficiency. CRC Press eBooks. https://doi.org/10.1201/b13564-28
364. Lim, H. J., Kwon, Y. J., Lee, J. E., & Cho, S. (2013). Original article : Reconsideration of Psychasthenia- Two Cases. 동의신경정신과학회지.
365. Lim, H., Kwon, Y.-J., Lee, J.-E., & Cho, S. (2013). Reconsideration of Psychasthenia- Two Cases. Journal of Oriental Neuropsychiatry. https://doi.org/10.7231/jon.2013.24.3.245
366. LIMA, F. S., SANTOS, F. A. C., FARIAS, L. J. D. S., OLIVEIRA, T. A. S. D., & DUARTE, E. A. A. (2023). SUPLEMENTAÇÃO COM PROBIÓTICOS NA PROFILAXIA DE TRANSTORNOS DEPRESSIVOS: PESQUISA BIBLIOMÉTRICA. Editora Health eBooks. https://doi.org/10.29327/5208636.2-16
367. Lin, Z., & Richard, W. D. (2012). Changes of Sympathovagal Balance Measured by Heart Rate Variability in Gastroparetic Patients Treated with Gastric Electrical Stimulation. InTech eBooks. https://doi.org/10.5772/23052
368. Louis, E. K. S., Boeve, A., & Boeve, B. F. (2017). <scp>REM</scp><scp>S</scp>leep <scp>B</scp>ehavior <scp>D</scp>isorder in <scp>P</scp>arkinson's <scp>D</scp>isease and <scp>O</scp>ther <scp>S</scp>ynucleinopathies. Movement Disorders. https://doi.org/10.1002/mds.27018
369. Luthra, M. (2017). Depression: Current Scenario with reference to India. Indian Journal of Community Health. https://doi.org/10.47203/ijch.2017.v29i01.001
370. López, C. A., Fernández, D. S., López, M. M., Gázquez, M. C. G., & Pérez, A. V. (2019). Cuidados de enfermería en recién nacidos con síndrome de abstinencia.
371. L�pine, J.-P., & Briley, M. (2004). The epidemiology of pain in depression. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/hup.618
372. Madan, A., Frueh, B. C., Fowler, J. C., Stomberg, S., Bradshaw, M. R., Kelly, K. R., Weinstein, B., Luttrell, M., Danner, S. G., & Beidel, D. C. (2020). “Operator syndrome”: A unique constellation of medical and behavioral health-care needs of military special operation forces. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/0091217420906659
373. Madruga, M. L. L. H., Melo, G. B., Martins, J. M., Aranha, R. E. L. D. B., Marinho, J. C. R. L., Alves, N. T., Estudo, E., Revisão, U., & Literatura, D. (2018). Estudo Eletroencefalográfico De Indivíduos Com Dor Crônica Decorrente Da Fibromialgia: Uma Revisão Da Literatura. Scientific Research and Reviews. https://doi.org/10.28933/srr-2018-06-28100
374. Maj, M. (2007). Delusions in Major Depressive Disorder: Recommendations for the DSM-V. Psychopathology. https://doi.org/10.1159/000109948
375. Maj, M. (2023). Understanding depression beyond the “mind‐body” dichotomy. World Psychiatry. https://doi.org/10.1002/wps.21142
376. Mamidi, P., & Gupta, K. (2018). Uraga grahonmada: Extrapyramidal movement disorder?/Tourette syndrome-plus?. Indian Journal of Health Sciences and Biomedical Research (KLEU). https://doi.org/10.4103/kleuhsj.kleuhsj_10_18
377. Manber, R., Ong, J. C., & Carlyle, E. (2008). Diagnostic Tools for Insomnia. CRC Press eBooks. https://doi.org/10.3109/9781420019926-6
378. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
379. Maramis, M. M. (2009). Mengenal Gangguan Mood pada Perempuan.
380. Maria, C.-G. C., Oj, C., & Martínez-Royert, J. C. (2021). “Clinical Study of Memory Disorders in Aging Patients with Associated Cardiovascular, Neurological, Neurobehavioral and Metabolic Diseases”. A Review. https://doi.org/10.47363/jccsr/2020(3)167
381. Marklin, M., Killion, B., O’Connor, E., Renschler, K., & Freeman, J. B. (2023). Comorbid OCD and ADHD in youth: Clinical implications and treatment recommendations. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30743
382. Martens, W. H. J., & Kahn, W. A. (2003). Emotional Capacities and Sensitivity in Psychopaths.
383. Martins, M. B., Boff, C., & Ávila, C. T. (2021). Desafios da avaliação neuropsicológica: depressão x declínio cognitivo na pessoa idosa / Neuropsychological assessment: depression versus cognitive decline in the elderly. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv4n5-408
384. Martínez, A. A. B. (2019). A Way of Bridging the Gap between Psychological Treatments and Antidepressant Medication. International Journal of Depression and Anxiety. https://doi.org/10.23937/ijda-2017/1710010
385. Martínez, A. R., Argüelles, P. P., Cucurella, M. M., Llort, A. J., Camacho, J. A., & Plana, J. C. (2008). Manifestaciones neurológicas en el síndrome hemolítico urémico. Revista de Neurología. https://doi.org/10.33588/rn.4704.2008249
386. Martínez‐Salio, A., Soler-Algarra, S., Calvo-Garcia, I., & Sánchez-Martín, M. (2007). Síndrome de ingesta nocturna relacionada con el sueño con respuesta al topiramato. Revista de Neurología. https://doi.org/10.33588/rn.4505.2007188
387. Marín‐Medina, D. S., Camacho-Gomez, O. L., Martínez, J. A. E., Toro, C. J., & Sánchez‐Duque, J. A. (2024). Deprescripción en el anciano con demencia. Acta neurológica colombiana. https://doi.org/10.22379/anc.v40i2.1829
388. Master, C. L., Bacal, D., Grady, M. F., Hertle, R. W., Shah, A. S., Strominger, M. B., Whitecross, S., Bradford, G. E., Lum, F., & Donahue, S. P. (2022). Vision and Concussion: Symptoms, Signs, Evaluation, and Treatment. PEDIATRICS. https://doi.org/10.1542/peds.2021-056047
389. Mateus, L. A. S. (2022). Games violentos e sua relação com comportamento social das crianças. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.19
390. Matheson, J. K. (2008). Sleep disorders in the elderly.. Medicine and health, Rhode Island.
391. Mazza, M., Faia, V., Paciello, N., Marca, G. D., & Mazza, S. (2002). Sleep disorders in childhood: a review.. PubMed.
392. Mazzoni, P., Kimhy, D., Khan, S., Posner, K., Maayan, L., Eilenberg, M., Walsh‐Messinger, J., Kestenbaum, C. J., & Corcoran, C. M. (2009). Childhood Onset Diagnoses in a Case Series of Teens at Clinical High Risk for Psychosis. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2008.0105
393. McArdle, P. (2004). Attention-deficit hyperactivity disorder and life-span development. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.184.6.468
394. McNamara, P., Durso, R., & Auerbach, S. (2002). Dopaminergic syndromes of sleep, mood and mentation: Evidence from Parkinson's disease and related disorders. Sleep and Hypnosis.
395. McQuillan, R. (2020). Symptoms other than pain. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0065
396. McVicar, K. (2006). Seizure-like States. Pediatrics in Review. https://doi.org/10.1542/pir.27.5.e42
397. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
398. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
399. Mehboob, R. (2022). Eating Disorders. DIET FACTOR (Journal of Nutritional & Food Sciences). https://doi.org/10.54393/df.v3i1.51
400. Mehdiratta, N., Kalita, S., & Hirsch, A. R. (2023). Generalized Restless Body Syndrome: A case of opioid withdrawal- induced restlessness extending beyond the legs. https://doi.org/10.14293/p2199-8442.1.sop-.ptttfx.v1
401. Meinck, H., & Ringleb, P. A. (2012). Neurologische Symptome mit Beeintraechtigung der Fahreignung.
402. Mellero, D. (2007). Ansiedade em situações de convívio social em idosos.
403. Mellman, T. A. (1989). Electroencephalographic Sleep in Panic Disorder. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1989.01810020080013
404. Menezes, M. C. D. C., Gonçalves, L. G. V., Chaves, S. C. D. S., Jaime, T. F. M., Oliveira, I. C. Z., Sobrinho, K. D. L., Oliveira, L. L. D., Araújo, J. V. L. D., Gurian, F. G., Soares, I. L. T., Nero, L. D., Pereira, P. H. D. O., Moraes, F. D. C., & Teixeira, G. P. (2023). MAIN CAUSES OF INTENTIONAL ACCIDENTS IN PEDIATRICS AND CLINICAL MANIFESTATIONS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593712308095
405. Menzel, J. E., & Thompson, J. K. (2010). Food Addiction. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0365
406. Mervis, C. Β., Morris, C. A., Klein-Tasman, B., Velleman, S. L., & Osborne, L. R. (2015). 7q11.23 Duplication Syndrome.
407. Mihaylova, V., & Jung, H. H. (2017). Muskelkrämpfe – die neurologische Perspektive. Praxis. https://doi.org/10.1024/1661-8157/a002902
408. Miller, S. P., & Latal, B. (2009). Neurocognitive outcomes of term infants with perinatal asphyxia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511581281.050
409. Mills, D. S. (2014). Clinical animal behaviour models of stereotypic behaviour and underlying cognition.
410. Miranda, L. A., Lopes, M. L., Ribeiro, M. H., & Benincasa, M. (2014). Transtorno Alimentar e Relações familiares: estudo de caso.
411. Mirawati, D. K. (2018). Managing antiepileptic drug, Starting, Changing and Stopping AED’s.
412. Mircher, C., Cieuta‐Walti, C., Marey, I., Rebillat, A., Cretu, L., Milenko, E., Conte, M., Sturtz, F., Rethoré, M. O., & Ravel, A. (2017). Acute Regression in Young People with Down Syndrome. Brain Sciences. https://doi.org/10.3390/brainsci7060057
413. Mirzaa, G., Conway, R. L., Graham, J. M., & Dobyns, W. B. (2013). PIK3CA-Related Segmental Overgrowth.
414. Mitchnick, D., Clemens, C., Kagereki, J., Kumar, V., & Fraser, S. N. (2017). Measuring the Written Language Disorder among Students with Attention Deficit Hyperactivity Disorder. The Journal of Writing Analytics. https://doi.org/10.37514/jwa-j.2017.1.1.07
415. Modigh, K., Berggren, U., & Sehlin, S. (1998). [High risk for children with DAMP/ADHD to become addicts later in life].. PubMed.
416. Modugno, N., Lena, F., Biasio, F. D., Cerrone, G. E., Ruggieri, S., & Fornai, F. (2013). A clinical overview of non-motor symptoms in Parkinson's Disease.. PubMed.
417. Mohammadi, M. R., & Akhondzadeh, S. (2007). Pharmacotherapy of attention-deficit/hyperactivity disorder: nonstimulant medication approaches. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.7.2.195
418. Monràs, M., Ortega, L., Mondón, S., López-Lazcano, A., & Lligoña, A. (2020). Adicciones: viejas terapias grupales (TG) y nuevos pacientes. Adicciones. https://doi.org/10.20882/adicciones.1355
419. Montes, A. B., & Rey, J. A. (2009). Iloperidone (Fanapt): An FDA-Approved Treatment Option for Schizophrenia. P & T.
420. Monti, J. M., & Pandi‐Perumal, S. R. (2014). Role of zolpidem in the management of primary and comorbid insomnia. https://doi.org/10.2217/fmeb2013.13.146
421. Monti, M. M., Laureys, S., & Owen, A. M. (2010). The vegetative state. BMJ. https://doi.org/10.1136/bmj.c3765
422. Morales, M. V., & García-Camba, E. (2007). Psicopatología y cirugía ortognática: La dismorfofobía.
423. Moreno, R. A., Moreno, D. H., & Ratzke, R. (2005). Diagnóstico, tratamento e prevenção da mania e da hipomania no transtorno bipolar. Archives of Clinical Psychiatry (São Paulo). https://doi.org/10.1590/s0101-60832005000700007
424. Morris, J. G., & McManus, D. Q. (1991). The neurology of aging: normal versus pathologic change.. PubMed.
425. Mossaheb, N., Schloegelhofer, M., Schaefer, M., Fusar‐Poli, P., Smesny, S., McGorry, P. D., Berger, G., & Amminger, G. P. (2012). Long-Chain Omega-3 Fatty Acids and Psychotic Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-62703-215-5_9
426. Moura, G. S., Neves, L. M. T., Giorelli, A. S., Florido, P., & Gomes, M. D. M. (2013). Transtornos do sono: visão geral Sleep disorders: overview.
427. Mumma, K., Remillard, E., Umar, T., Bhookya, D., & Rogers, W. A. (2023). UNDERSTANDING EVERYDAY NEEDS OF OLDER ADULTS WITH MACULAR DEGENERATION OR GLAUCOMA. Innovation in Aging. https://doi.org/10.1093/geroni/igad104.0127
428. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
429. Nahler, G. (2009). labelling phenomenon. Dictionary of Pharmaceutical Medicine. https://doi.org/10.1007/978-3-211-89836-9_767
430. Nakayama, H., Mihara, S., Sakuma, H., Kitamura, D., & Higuchi, S. (2014). SY08-3 * CO-MORBIDITY OF INTERNET ADDICTION. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agu052.39
431. Nava, G. M. (2018). Depression: From Sorrow to Melancholia. Scholarly Journal of Psychology and Behavioral Sciences. https://doi.org/10.32474/sjpbs.2018.01.000106
432. Neal, S., & Fields, K. B. (2010). Peripheral nerve entrapment and injury in the upper extremity.. PubMed.
433. Neto, L. C. D. S., Miranda, G. A., Cunha, L. L. G. D., Canto, B. E. S., Strufaldi, V. P., Tetti, M. F., Akerman, M., & Matos, L. L. D. (2013). Consequências individuais e socioeconômicas da síndrome da apneia obstrutiva do sono. ABCS Health Sciences. https://doi.org/10.7322/abcshs.v38i1.6
434. Nielsen, J. F., Klemar, B., Hansen, H., & Sinkjær, T. (1995). A new treatment of spasticity with repetitive magnetic stimulation in multiple sclerosis.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.58.2.254-a
435. Nolen–Hoeksema, S. (1998). Ruminative Coping with Depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511527869.011
436. Norton, C., Williams, J., Taylor, C., Nunwa, A., & Whayman, K. (2008). Chapter 17 Neurological bowel care. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199298655.003.0017
437. Norton, C., Williams, J., Taylor, C., Nunwa, A., & Whayman, K. (2008). Chapter 19 Bowel care and vulnerable groups. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199298655.003.0019
438. Novati, A. (2012). Sleep loss, brain vulnerability and psychopathology: experimental studies on the neurobiological consequences of chronic sleep restriction in rats.
439. Nubli, M. A. (2019). Depresi Pada Penderita Cedera Kepala. https://doi.org/10.35816/jiskh.v10i2.151
440. Nurlaili, N. (2012). MENOPAUSE DAN PENGARUHNYA DALAM KEHIDUPAN PERKAWINAN. Marwah Jurnal Perempuan Agama dan Jender. https://doi.org/10.24014/marwah.v11i2.509
441. Oh, S.-H. (2019). 12 - CAN RORSCHACH DIFFERENTIATE BIPOLAR DISORDER FROM DEPRESSIVE DISORDER? : COMPARISON OF RORSCHACH SCORES BETWEEN BIPOAR DEPRESSION AND UNIPOLAR DEPRESSION. https://doi.org/10.26226/morressier.5d1a038757558b317a13f97e
442. Okechukwu, C. E. (2021). Neuropsychopathology of gambling disorder. MGM Journal of Medical Sciences. https://doi.org/10.4103/mgmj.mgmj_32_21
443. Okechukwu, C. E. (2021). Working permanent night shifts and insomnia among nurses. Occupational Medicine. https://doi.org/10.1093/occmed/kqab053
444. Oliete, B. M. (2012). Delirium en el anciano: revisión. Agathos: Atención sociosanitaria y bienestar.
445. Olmos-López, A., Ibarra-Aguilar, J., Cornelio-Nieto, J. O., Ocaña-Hernández, L. A., Márquez-Amaya, M. A., Luna-López, N. A., Reséndiz-Aparicio, J. C., & Rodríguez‐Leyva, I. (2019). Clinical guideline: status epilepticus in children and adults. DELETED. https://doi.org/10.24875/rmn.m19000031
446. Olszewska, A., Daktera-Micker, A., Cieślińska, K., Firlej, E., & Biedziak, B. (2017). Auto-aggressive behavior in dental patients. Journal of Medical Science. https://doi.org/10.20883/jms.2017.210
447. Orme, S., & Harari, D. (2020). Bladder and bowels. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0060
448. Os, J. V., Praag, H. M. V., & Kloet, E. R. D. (2004). Stress, the brain and depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544422.010
449. Osgood, N. J. (1991). Psychological factors in late-life suicide.. PubMed.
450. Ozdemir, D., & Sahni, S. (2019). Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.4893
451. Pablo, G. S. D. (2018). Mental Capacity and Decision Making in Bipolar Disorder. Peer Reviewed Journal of Forensic & Genetic Sciences. https://doi.org/10.32474/prjfgs.2018.03.000152
452. Papageorgopoulou, E., & Jones, E. J. H. (2025). Infant Precursors to Autism. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.55
453. Paradela, E. M. P. (2011). Depressão em idosos. Revista Hospital Universitário Pedro Ernesto (TÍTULO NÃO-CORRENTE). https://doi.org/10.12957/rhupe.2011.8850
454. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
455. Park, H. S., Joo, E. Y., & Hong, S. B. (2009). Sleep onset Insomnia. Journal of Korean Sleep Research Society. https://doi.org/10.13078/jksrs09015
456. Parmet, S. (2003). Insomnia. JAMA. https://doi.org/10.1001/jama.289.19.2466
457. Parmet, S., Lynm, C., & Glass, R. M. (2003). Insomnia. JAMA. https://doi.org/10.1001/jama.289.19.2602
458. Paruthi, S. (2020). Telemedicine in Pediatric Sleep. Sleep Medicine Clinics. https://doi.org/10.1016/j.jsmc.2020.07.003
459. Passerieux, C. (2013). [Psychological interventions in the treatment of schizophrenia].. PubMed.
460. Pathak, A., Rai, J., Rai, N., Singh, R., & Bhatt, G. (2023). AB1367 EFFECTIVENESS OF REHABILITATION STRATEGIES IN PRIMARY FIBROMYALGIA SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS. https://doi.org/10.1136/annrheumdis-2023-eular.295
461. Patnana, C. (2021). Leaf Roller and its Management. https://doi.org/10.36648/iprjpp.21.s1.003
462. Patten, S. B. (2015). Major depressive disorder: reification and (maybe) rheostasis. Epidemiology and Psychiatric Sciences. https://doi.org/10.1017/s2045796015000682
463. Patti, L., & Gupta, M. (2019). Change In Mental Status. StatPearls.
464. Paunescu, R., & Micluția, I. (2012). P-196 - Cognitive impairment in depressed and euthymic patients with bipolar disorder. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)74363-8
465. Pearlstein, T. (2012). Psychotropic medications and other non-hormonal treatments for premenstrual disorders. Menopause international. https://doi.org/10.1258/mi.2012.012010
466. Pegrum, S. N. (2009). Putting the pieces together: The subjective experience of anorexia nervosa over the course of the disorder. https://doi.org/10.4226/66/5a95ee1bc6804
467. Pereira, S. M. P., Guimarães, S. K. G., Marques, A., & Borges, S. (2008). Electroconvulsivotherapy in the elderly, indications, risks and side-effects. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2008.01.611
468. Peretti, C.-S., Ferreri, F., & Crucis, B. (2009). Troubles cognitifs dans la dépression. La Lettre du psychiatre.
469. Persinger, M. A. (1989). Geophysical Variables and Behavior: LV. Predicting the Details of Visitor Experiences and the Personality of Experients: The Temporal Lobe Factor. Perceptual and Motor Skills. https://doi.org/10.2466/pms.1989.68.1.55
470. Pervanidou, P., & Chrousos, G. P. (2011). Stress and obesity/metabolic syndrome in childhood and adolescence. International Journal of Pediatric Obesity. https://doi.org/10.3109/17477166.2011.615996
471. Peña, M. A. M. (2013). Síndrome de sobreentrenamiento. IATREIA.
472. Pich, E. M., Heidbreder, C., Mugnaini, M., & Teneggi, V. (2003). Molecular and Behavioral Aspects of Nicotine Dependence and Reward. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-343-9_16
473. Pies, R. W. (2007). How Long to Wait for an Antidepressant to 'Work'. Current psychiatry.
474. Pignalberi, C., Ricci, R. P., & Santini, M. (2002). [Psychological stress and sudden death].. PubMed.
475. Pitulei, V. V. (2022). POSTCOVID DEPRESSION: DIAGNOSIS AND WAYS TO OVERCOME IT. Прикарпатський вісник наукового товариства імені Шевченка ПУЛЬС. https://doi.org/10.21802/2304-7437-2021-2022-16-17(61-62)-93-99
476. Pizov, A. V. (2022). Peculiarities of insomnia in men and women at different age periods. Meditsinskiy sovet = Medical Council. https://doi.org/10.21518/2079-701x-2022-16-21-112-118
477. Poskitt, E., & Chiumello, G. (2002). Prader–Willi and other syndromes. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544675.011
478. Powlishta, K. K., Storandt, M., Mandernach, T., Hogan, E., Grant, E., & Morris, J. C. (2004). Absence of Effect of Depression on Cognitive Performance in Early-Stage Alzheimer Disease. Archives of Neurology. https://doi.org/10.1001/archneur.61.8.1265
479. Praag, H. M. V. (1998). Anxiety and increased aggression as pacemakers of depression. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1998.tb05971.x
480. Prabu, M. I. J., & Sharma, C. P. (2021). STRESS AND HYPERTENSION. IDC International Journal. https://doi.org/10.47211/idcij.2021.v08i01.009
481. Prager, L. M. (2009). Depression and Suicide in Children and Adolescents. Pediatrics in Review. https://doi.org/10.1542/pir.30.6.199
482. Prasad, S., Kumar, A., & Rajeswari, K. (2024). Episodic Bout of Shouting: A Rare Variant of Childhood Obsessive Compulsive Disorder (OCD). International Journal of Research and Review. https://doi.org/10.52403/ijrr.20240572
483. Pressman, M. R. (2013). Complex (Including Violent) Sleep Behavior. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199795161.003.0036
484. Pujalte, G. G., & Benjamin, H. J. (2018). Sleep and the Athlete. Current Sports Medicine Reports. https://doi.org/10.1249/jsr.0000000000000468
485. Putra, H. G. S. A. (2015). GANGGUAN AFEKTIF BIPOLAR MANIA DENGAN PSIKOTIK: SEBUAH LAPORAN KASUS. DOAJ (DOAJ: Directory of Open Access Journals).
486. Pérez, J. A. H., Botina, A. D. M., Hormiga, M. P., & Sánchez, B. E. B. (2017). Trastornos de la alimentación: Anorexia nerviosa y bulimia nerviosa. RFS Revista Facultad de Salud. https://doi.org/10.25054/rfs.v9i1.1827
487. Rabins, P. V., & Slavney, P. R. (2008). Overview of Psychiatric Symptoms and Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195309430.003.0008
488. Radmanović, M. B., & Burgić, S.-S. (2020). Comorbidity in Children and Adolescents with ADHD. IntechOpen eBooks. https://doi.org/10.5772/intechopen.94527
489. Rahmawati, R. (2022). Menurunkan gejala kecemasan pada gangguan kecemasan umum dengan cognitive therapy. Procedia Studi Kasus dan Intervensi Psikologi. https://doi.org/10.22219/procedia.v10i4.19184
490. Raju, V., & Muthulakshmi, G. (2014). Impact of stress in work life balance among working people. South Asian Journal of Marketing & Management Research.
491. Ramakrishnan, N., Bansal, A., & Ponnish, A. S. (2022). Practical approach to sleep disordered breathing. Indian Journal of Respiratory Care. https://doi.org/10.5005/jp-journals-11010-02205
492. Ranganathan, A., & Beitman, B. D. (1998). Panic disorder: a different perspective.. PubMed.
493. Rani, M. K. S., Fathima, S. T., Gayathri, S. L., Pavani, M., & Swathi, Y. (2022). Detection of Autism Spectrum Disorder using Machine Learning. International Journal of Advanced Research in Science Communication and Technology. https://doi.org/10.48175/ijarsct-7600
494. Rasmussen, J., Blashill, A. J., Greenberg, J. L., & Wilhelm, S. (2013). Body Dysmorphic Disorder. https://doi.org/10.1002/9781118528563.wbcbt47
495. Ravishankar, K., & Bhatnagar, M. (2013). Faculty Opinions recommendation of Advanced interventions for headache.. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature. https://doi.org/10.3410/f.717992832.793473687
496. Reddy, M. S. (2014). Irritability as a Criterion in Diagnosis of Child and Adolescent Bipolar Disorder: Thorny Road Ahead. Indian Journal of Psychological Medicine. https://doi.org/10.4103/0253-7176.130954
497. Rehman, S. U., Perveen, A., & Hassan, A. (2019). Concept of depression and its management in unani system of medicine: A review. International Journal of Physical Education Sports and Health.
498. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
499. Renzullo, A. M., Benvenuto, S., Nait, G., & Pennesi, M. (2024). L'enuresi notturna: in quadramento e gestione. Medico e Bambino. https://doi.org/10.53126/meb43499
500. Restak, R. M. (1989). The brain, depression, and the immune system.. PubMed.
501. Riaz, Y., & Sergi, C. (2021). Feeding Disability In Children.
502. Ricciardelli, R., & Johnston, M. S. (2022). Police Mental Health and Wellness. Oxford Research Encyclopedia of Criminology and Criminal Justice. https://doi.org/10.1093/acrefore/9780190264079.013.752
503. Richards, M. (2019). Physical frailty and decline in general and specific cognitive abilities. Journal of Epidemiology & Community Health. https://doi.org/10.1136/jech-2019-213410
504. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
505. Robinson, E., Neale, B. M., & Daly, M. J. (2017). Diagnosis and Epidemiology of Pediatric Psychiatric Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190681425.003.0058
506. Rodrigues, F. D. A. A. (2022). WHAT HAPPENS IN THE BRAIN OF A PERSON WITH DISORDER. International Journal of Health Science. https://doi.org/10.22533/at.ed.1592442202087
507. Rodrigues, L. D. S., Torres, L. D. A., Fernandes, F. D. L., & Coutinho, J. S. D. C. (2014). OS BENEFÍCIOS DO USO DA BANDAGEM ELÁSTICA FUNCIONAL EM HEMIPARÉTICOS. Encontro Regional Centro-Oeste 2014.
508. Rodríguez, E. O., Esquivel, P. S., & Triana, I. M. (2024). Un panorama actualizado de la dispepsia. Revista médica de Panamá. https://doi.org/10.37980/im.journal.rmdp.20242296
509. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
510. Rosenbaum, J. F., & Zajecka, J. (1997). Clinical management of antidepressant discontinuation.. PubMed.
511. Rosenow, F. (2021). Influenced by Bipolar Confusion Illness while Overthinking and Melancholy.
512. Rowe, P. C., Underhill, R., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2017.00121
513. Ruff, R. M., Silver, C., Iverson, G. L., BARTH, J., BROSHEK, D., Bush, S. B., Koffler, S. P., & Reynolds, C. W. (2007). Learning disabilities: The need for neuropsychological evaluation. Archives of Clinical Neuropsychology. https://doi.org/10.1016/j.acn.2007.09.006
514. Ruiz‐Rizzo, A. L., & Restrepo, F. L. (2008). Memoria explícita en el trastorno depresivo mayor. IATREIA. https://doi.org/10.17533/udea.iatreia.4479
515. Sa, H. (2013). Diabetes Mellitus And The Brain: Special Emphasis To Cognitive Function. International Journal of Diabetology & Vascular Disease Research. https://doi.org/10.19070/2328-353x-130007
516. Sachan, A., & Chaturvedi, T. (2012). Onychophagia (Nail biting), anxiety, and malocclusion. Indian Journal of Dental Research. https://doi.org/10.4103/0970-9290.107399
517. Sadleir, L. G., Scheffer, I. E., Smith, S., Connolly, M., & Farrell, K. (2009). Automatisms in Absence Seizures in Children With Idiopathic Generalized Epilepsy. Archives of Neurology. https://doi.org/10.1001/archneurol.2009.108
518. Saeed, S. A. (2009). Social Anxiety Disorder: An Update on Evidence-Based Treatment Options.
519. Sakakibara, R., & Katsuragawa, S. (2022). Depression and LUT (Psychogenic LUTS). https://doi.org/10.1007/978-981-16-7939-1_78-1
520. Sakauye, K., & Nininger, J. E. (2018). Trauma in Late Life. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190457136.003.0009
521. Salem, D. A. S. A. (2023). The Effect of Vitamin D, B12, and Folic Acid Supplements in Relieving Major Depressive Symptoms, General Anxiety Disorder among Adults and Adolescents - A Systemic Article Review. Journal of Medical Science And clinical Research. https://doi.org/10.18535/jmscr/v11i8.13
522. Salman, H. A. (2025). Psychological Changes in the form of Aging. https://doi.org/10.55677/csrb/06-v02i09y2025
523. Sandi, C. (2013). Stress and cognition. Wiley Interdisciplinary Reviews Cognitive Science. https://doi.org/10.1002/wcs.1222
524. Santana, L., Jeremias, D., Braga, F. I. L., Mesquita, B., & Santos, C. P. (2024). Binge, Purge, and Wander: Navigating Bulimia and Attention Deficit Hyperactivity Disorder (ADHD). Cureus. https://doi.org/10.7759/cureus.69076
525. Santeusanio, F. (2012). Quadri internistici ed endocrinologici connessi alla disabilitŕ grave. CHILD DEVELOPMENT & DISABILITIES - SAGGI. https://doi.org/10.3280/cdd2010-003010
526. Sanz, G. L., Ruíz, E. C., & Vázquez, L. S. (2015). Síndrome confusional ag udo en pacientes de edad avanzada con fractura de fémur. Ágora de enfermería.
527. Saradhadevi, S., & Hemavathy, V. (2022). Anxiety Disorders. Cardiometry. https://doi.org/10.18137/cardiometry.2022.24.10101012
528. Satoh‐Kuriwada, S., Shoji, N., Kawai, M., Uneyama, H., Kaneta, N., & Sasano, T. (2009). Hyposalivation Strongly Influences Hypogeusia in the Elderly. JOURNAL OF HEALTH SCIENCE. https://doi.org/10.1248/jhs.55.689
529. Sazonov, S. (2014). EPA-0651 – The complexity of psychopathological symptom as a possible indication of mental disease's etiology. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78023-x
530. Schachter, S. C. (2007). Overview of Epilepsy and Seizures. https://doi.org/10.1093/oso/9780195330892.003.0004
531. Schenck, C. H. (2003). Assessment and Management of Insomnia. JAMA. https://doi.org/10.1001/jama.289.19.2475
532. Schlindwein‐Zanini, R., Ikino, C. M. Y., Mada, M. S., & Ferreira, Z. C. G. (2021). ALTERAÇÕES PSICOLÓGICAS EM PACIENTES COM QUEIXA DE PERDA AUDITIVA. Arquivos Catarinenses de Medicina. https://doi.org/10.63845/kgbt6k38
533. Schneier, F. R., Bruce, L. C., & Heimberg, R. G. (2014). Social Anxiety Disorder (Social Phobia). American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg18
534. Scholte, W. F., Verhaak, L., Lok, A. S., & Ghafoerkhan, R. (2017). The mental health of trafficked persons. Routledge eBooks. https://doi.org/10.4324/9781315709352-23
535. Schroeder, K. (2010). The 10-minute Clinical Assessment.
536. Schroeder, R. W., Martin, P. K., & Walling, A. (2019). Neuropsychological Evaluations in Adults.. PubMed.
537. Schwager, H., & BSN, L. T. S. (2019). 09 - TREATMENT OF IATROGENIC OPIOID DEPENDANCE USING BUPERNORPHINE IN PATIENTS WITH CHRONIC PAIN A TELE-BEHAVIORAL MEDICINE PROTOCOL. https://doi.org/10.26226/morressier.5d1a038357558b317a140c62
538. Scott, D. A., & Sherr, E. H. (2019). RERE-Related Disorders.
539. Seifert, B., Lukáš, K., Charvátová, E., Vojtíšková, J., Koudelka, T., Hep, A., Bureš, J., Jirásek, V., & Dítě, P. (2007). Lower dyspeptic syndrome. Recommended diagnostic and therapeutic procedures for general practitioners 2006.
540. Sejdić, E., Malandraki, G. A., & Coyle, J. L. (2018). Computational Deglutition: Using Signal- and Image-Processing Methods to Understand Swallowing and Associated Disorders [Life Sciences]. IEEE Signal Processing Magazine. https://doi.org/10.1109/msp.2018.2875863
541. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
542. Selby, E. A., Panza, E., & Plasencia, M. (2019). Positive Emotion Dysregulation in Eating Disorders and Obesity. https://doi.org/10.1093/oxfordhb/9780190653200.013.26
543. Seligman, L. D., Swedish, E. F., & Ollendick, T. H. (2014). Anxiety Disorders in Children. https://doi.org/10.1002/9781394259359.ch7
544. Seltzer, A., & Hoffman, B. F. (1980). Drug compliance and the psychiatric patient.. PubMed.
545. Serrano, J. L., Vila, S., Vidal, R. C., Padilla, E. B., Lamora, N. S., Mollà, L., Rodríguez, A. M., & López, L. M. M. (2017). COMORBILIDAD ENTRE DEPRESIÓN Y CONDUCTAS IMPULSIVAS: UN CASO DE URGENCIA NEGATIVA.
546. Serrano, L., & Néstor, A. (2019). Proceso de Atención de Enfermería en neonato con diagnóstico de Síndrome de Abstinencia Neonatal, perteneciente al área CIN en el Hospital General Guasmo Sur..
547. Shams, J., Rahmani, B., Asefi, F., & Daneshfar, S. (2010). CATATONIA DEVELOPMENT IN A SCHIZOAFFECTIVE PATIENT FOLLOWING ELECTROCONVULSIVE THERAPY: CASE REPORT.
548. Sharma, S., Kishore, J., & Gupta, V. (2014). Adolescent Mental Health: From Normalcy to Illness. Indian Journal of Youth and Adolescent Health.
549. Sharp, L. K., & Lipsky, M. S. (2002). Screening for depression across the lifespan: a review of measures for use in primary care settings.. PubMed.
550. Sharpe, M., & Wilks, D. (2002). ABC of psychological medicine: Fatigue. BMJ. https://doi.org/10.1136/bmj.325.7362.480
551. Sheets, E. S., & Brosse, A. L. (2010). Major Depressive Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0522
552. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
553. Silva, M., Santillana, R. D. H., Martı́n, M. Á., & Fiori, E. (2025). Post traumatic stress disorder in postpartum: when guilt delays recovery. A case report. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2025.1949
554. Singh, P. K. (2015). Psychogenic Headache in School Going Children. Indian Journal of Health and Wellbeing.
555. Singh, R., & Chaudhury, S. (2009). Hyponatremia-induced psychosis in an industrial setting. Industrial Psychiatry Journal. https://doi.org/10.4103/0972-6748.62277
556. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
557. Singh, S., & Vats, A. (2020). Impact of physiological and psychological stress on students. Deleted Journal.
558. Skraban, C., Grand, K., & Deardorff, M. A. (2019). WDR26-Related Intellectual Disability.
559. Smith, M. B. (2023). Addiction as a Sui Generis Force: An Opinion Overview. https://doi.org/10.9734/bpi/nramms/v3/6349a
560. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
561. Smith, S. S. (2019). Insomnia and Clinical Sleep Disturbance in Later Life. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.419
562. Soares, C. S., & Almondes, K. M. D. (2014). PERJUICIOS DE LA FALTA DEL SUEÑO PARA LO DESEMPEÑO COGNITIVO DE PROCESOS ATENCIONALES. VI Congreso Internacional de Investigación y Práctica Profesional en Psicología XXI Jornadas de Investigación Décimo Encuentro de Investigadores en Psicología del MERCOSUR.
563. Soares, E. B., Pires, J. B., Menezes, M. D. A., Santana, S. K. S. D., & Fraga, J. (2010). Fonoaudiologia X ronco/apneia do sono. Revista CEFAC. https://doi.org/10.1590/s1516-18462010000200019
564. Sommer, I. E., & Arango, C. (2017). Moving interventions from after to before diagnosis. World Psychiatry. https://doi.org/10.1002/wps.20454
565. Spector, P. E. (2002). Employee Control and Occupational Stress. Current Directions in Psychological Science. https://doi.org/10.1111/1467-8721.00185
566. Stafstrom, C. E. (1995). Neonatal Seizures. Pediatrics in Review. https://doi.org/10.1542/pir.16.7.248
567. Stearns, M., McCrae, C. S., Curtis, A., Nair, N., Hayse, B., Nadorff, D., & Wilkerson, A. K. (2024). Adolescent sleep mediates maternal depressive problems and parenting behaviors: daughter and son differences in a majority Black and Hispanic sample. Journal of Clinical Sleep Medicine. https://doi.org/10.5664/jcsm.10996
568. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
569. Steineck, G., Bergmark, K., Henningsohn, L., al‐Abany, M., Dickman, P. W., & Helgason, Á. R. (2002). Symptom Documentation in Cancer Survivors as a Basis for Therapy Modifications. Acta Oncologica. https://doi.org/10.1080/02841860260088782
570. Stern, J. M., & Engel, J. (2013). Atlas of EEG Patterns.
571. Stewart, S. M. (2013). Depression. The Encyclopedia of Cross‐Cultural Psychology. https://doi.org/10.1002/9781118339893.wbeccp158
572. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
573. Stores, G. (2009). Signs of unsatisfactory sleep. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199560837.003.0005
574. Stores, G. (2009). What is sleep?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199560837.003.0003
575. Stratakis, C. A., Gold, P. W., & Chrousos, G. P. (1995). Neuroendocrinology of Stress: Implications for Growth and Development. Hormone Research. https://doi.org/10.1159/000184269
576. Strober, M., & Klump, K. L. (2002). Neurobiology of eating disorders. https://doi.org/10.1093/oso/9780195141733.003.0018
577. Stubbe, D. (2007). Child and adolescent psychiatry : a practical guide. Lippincott Williams & Wilkins eBooks.
578. Subramonian, A., & Featherstone, R. (2020). Interventions for the Prevention of Sudden Infant Death Syndrome and Sudden Unexplained Death in Infancy: A Review of Guidelines [Internet].
579. Sugimoto, A., Futamura, A., & Kawamura, M. (2013). [Epilepsy and cognitive dysfunction].. PubMed.
580. Sugumar, S., & Raguram, G. (2019). Insomnia-Some Issues and Remedical Measures. Indian Journal of Public Health Research & Development. https://doi.org/10.5958/0976-5506.2019.02822.5
581. Sukumar, B. S., & Shashirekha, H. K. (2015). CONSTIPATION CURE AND TREATMENT THROUGH DIET, YOGA, HOME REMEDIES. International Journal of Ayurveda and Pharma Research.
582. Sumiyoshi, T., Matsuoka, T., & Kurachi, M. (2012). Role for Pituitary Neuropeptides in Social Behavior Disturbances of Schizophrenia. InTech eBooks. https://doi.org/10.5772/52326
583. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. JBI Library of Systematic Reviews. https://doi.org/10.11124/jbisrir-2010-726
584. Sung, H. C., & Chang, A. B. (2010). The effectiveness of preferred or familiar music listening on behavioural and psychological symptoms of institutionalised older adults with dementia: a systematic review. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/01938924-201008341-00020
585. Surova, G., Ulke, C., Schmidt, F., Hensch, T., Sander, C., & Hegerl, U. (2020). Fatigue and brain arousal in patients with major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience. https://doi.org/10.1007/s00406-020-01216-w
586. Sutton, F., Bârcă, D., Komoltsev, I., Craiu, D., Guekht, A., Oertzen, T. J. V., & Cock, H. R. (2020). Testing blood and CSF in people with epilepsy: a practical guide. Epileptic Disorders. https://doi.org/10.1684/epd.2020.1191
587. Suárez, A. L. Á. (2022). Evaluación del efecto antidepresivo del secretoma derivado de células madre mesenquimáticas precondicionadas en un modelo animal de trastorno depresivo mayor. https://doi.org/10.52611/11447/6617
588. Swatko, T., Blicharz, M., Czubala, M., Bartosik-Zielińska, D., Blicharz, A., & Bartosik, M. (2023). Effects of creatine supplementation on brain in the healthy population. Journal of Education Health and Sport. https://doi.org/10.12775/jehs.2023.13.04.017
589. Syed, A. (2019). Migraine headache. International Journal of Biology Sciences. https://doi.org/10.33545/26649926.2019.v1.i2a.11
590. Szkodny, L. E., Jacobson, N. C., Llera, S. J., & Newman, M. G. (2014). Generalized Anxiety Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg19
591. Tagaya, H., Murayama, N., & Hakamata, Y. (2012). [Definitions and clinical classifications of sleep disorders].. PubMed.
592. Tani, M., & Iwanami, A. (2013). [Disorder of train of thought in the elderly].. PubMed.
593. Taylor, M. A. (1999). Obsessional Syndromes. https://doi.org/10.1093/oso/9780195130379.003.0014
594. Tedyanto, E. H., Adnyana, I. M. O., & Widyadharma, I. P. E. (2023). Tension-type Headache and Migraine as Manifestations of Chronic Post-Traumatic Headache. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v50i2.528
595. Teja, N., Gummadi, O. D., Devi, B. V., & Pavani, N. (2020). Evaluation of Depressant Activity on Mansoa alliacea on Rats. Acta Scientific Pharmaceutical Sciences. https://doi.org/10.31080/asps.2020.04.0617
596. Thakur, A., Choudhary, D., Kumar, B., & Chaudhary, A. (2021). A Review on Post-traumatic Stress Disorder (PTSD): Symptoms, Therapies and Recent Case Studies. Current Molecular Pharmacology. https://doi.org/10.2174/1874467214666210525160944
597. Thase, M. E., & Lang, S. S. (2004). Dysthymia in Children, Adolescents, and Young Adults. https://doi.org/10.1093/oso/9780195159189.003.0011
598. Timperley, J., Leeson, P., Mitchell, A. R., & Betts, T. (2007). Chapter 6 Troubleshooting pacemakers. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198571322.003.0006
599. Toki, K., Hourai, S., Yamashita, Y., Takada, S., & Shibata, S. (2005). Numbness and Pain Experienced by Stroke Victims. Journal of Japan Academy of Nursing Science. https://doi.org/10.5630/jans1981.25.2_75
600. Tom, N. R., Varghese, G. H., Lakshmi, S., & Sivakumar, T. (2014). Pre Menstrual Syndrome: Different Approaches of Management.
601. Torpy, J. M. (2006). Depression. JAMA. https://doi.org/10.1001/jama.295.3.348
602. Torpy, J. M. (2007). Acute Emotional Stress and the Heart. JAMA. https://doi.org/10.1001/jama.298.3.360
603. Torpy, J. M. (2009). Mild Cognitive Impairment. JAMA. https://doi.org/10.1001/jama.302.4.452
604. Tounian, P. (2007). Prise en charge de l’obésité de l’enfant. MTP. Médecine thérapeutique pédiatrie. https://doi.org/10.1684/mtp.2007.0130
605. Touzin, M. (2002). [Academic difficulties in hyperactive children].. PubMed.
606. Trill, M. D. (2012). Psychological aspects of depression in cancer patients: an update. Annals of Oncology. https://doi.org/10.1093/annonc/mds350
607. Trivedi, K., Kataria, L., & Patel, D. (2020). A COMPARATIVE STUDY EVALUATING THE DEPRESSIVE SYMPTOMS AND FUNCTIONAL OUTCOME IN PATIENTS TREATED WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS V/S SEROTONIN–NOREPINEPHRINE REUPTAKE INHIBITORS AS ANTIDEPRESSANT AGENTS IN MAJOR DEPRESSIVE DISORDER.
608. Trosch, R., Comella, C. L., Caroff, S. N., Ondo, W. G., Shillington, A. C., LaChappelle, B., Hauser, R. A., Correll, C. U., & Friedman, J. H. (2023). Reliability of the Clinician’s Tardive Inventory (CTI). CNS Spectrums. https://doi.org/10.1017/s1092852923001347
609. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
610. Tugendhaft, P. (2004). [The follow-up of antiepileptic drugs].. PubMed.
611. Tuovinen, S., Lahti‐Pulkkinen, M., Girchenko, P., Heinonen, K., Lahti, J., Reynolds, R. M., Hämäläinen, E., Villa, P., Kajantie, E., Laivuori, H., & Räikkönen, K. (2020). Maternal antenatal stress and mental and behavioral disorders in their children. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2020.09.063
612. Tyagi, S. (2013). DIET PLAN FOR MIGRAINE PATIENTS. Journal of Drug Discovery and Therapeutics.
613. Umar, S. H., & Hermida, H. (2019). PENERAPAN KECERDASAN EMOSIONAL DALAM MENGATASI STRES SISWA DI SEKOLAH. Foramadiahi Jurnal Kajian Pendidikan dan Keislaman. https://doi.org/10.46339/foramadiahi.v10i2.119
614. Urazán, D. T., Barragán, A. G., Hernández, K. D. C. P., & Gamboa, D. J. (2023). Afasia primaria progresiva variante no fluente/agramática. Acta neurológica colombiana. https://doi.org/10.22379/anc.v39i3.853
615. Ustaoglu, A., & Arvanitakis, M. (2023). Young GI angle: Imposter syndrome: What a young GI should know. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.12444
616. Vaknin, S. (2020). Eating Disorder and Personality Disorder. Journal of Obesity & Eating Disorders. https://doi.org/10.36648/2471-8203.6.4.56
617. Valente, S. M. (2015). Evaluating and Managing Insomnia: Non-pharmacological Treatments. Journal of Sleep Disorders & Therapy. https://doi.org/10.4172/2167-0277.1000189
618. Vallar, G., Sandroni, P., Rusconi, M. L., & Barbieri, S. (1991). Hemianopia, hemianesthesia, and spatial neglect. Neurology. https://doi.org/10.1212/wnl.41.12.1918
619. Vancleef, L. M. (2007). At risk for pain : pain-related anxiety, cognition, and processing biases. https://doi.org/10.26481/dis.20071108lv
620. Vashishta, I. (2022). Depression Among Youth. Authorea (Authorea). https://doi.org/10.22541/au.167226822.21087215/v1
621. Verges, D. P., & Weiss, J. P. (2015). Treatment of nocturia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198719113.003.0004
622. Verhagen, E. H., Hesselmann, G. M., Besse, T. C., & Graeff, A. D. (2005). [Palliative sedation].. PubMed.
623. Verklan, M. T. (2002). Physiologic Variability during Transition to Extrauterine Life. Critical Care Nursing Quarterly. https://doi.org/10.1097/00002727-200202000-00006
624. Verloès, A., Drunat, S., & Passemard, S. (2020). ASPM Primary Microcephaly.
625. Vilibić, M., Jukić, V., Vidović, A., & Brečić, P. (2013). Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.. PubMed.
626. Vuppalapati, C., Kedari, S., Ilapakurti, A., Kedari, S., & Shankar, J. (2019). Emotional Health: A Data Driven Approach to Understand our Emotions and Improve our Health. https://doi.org/10.1109/cse/euc.2019.00071
627. Wakefield, J. C. (2015). DSM-5 substance use disorder: how conceptual missteps weakened the foundations of the addictive disorders field. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.12446
628. Wakil, L., Meltzer‐Brody, S., & Girdler, S. S. (2012). Premenstrual Dysphoric Disorder: How to Alleviate Her Suffering; Accurate Diagnosis, Tailored Treatments Can Greatly Improve Women's Quality of Life. Current psychiatry.
629. Waller, D. G., Renwick, A., & Hillier, K. (2010). Medical Pharmacology and Therapeutics.
630. Walsh, S. K., & Harmon, D. (2019). AB210. 60. Shame and chronic pain: a narrative review. Mesentery and Peritoneum. https://doi.org/10.21037/map.2019.ab210
631. Wardani, I. A. K., & TIASTININGSIH, N. N. (2023). GANGGUAN TIDUR PADA PENDERITA GANGGUAN AFEKTIF BIPOLAR. Jurnal Hasil Penelitian dan Pengembangan (JHPP). https://doi.org/10.61116/jhpp.v1i3.158
632. Ware, W. A., Bonagura, J. D., & Scansen, B. A. (2021). Exercise Intolerance. CRC Press eBooks. https://doi.org/10.1201/9780429186639-9
633. Watari, K., & Gatz, M. (2002). Dementia: A Cross-Cultural Perspective on Risk Factors. Generations.
634. Wetterberg, L. (1987). La hormona melatonina como marcador de un subgrupo de depresión. Salud Mental.
635. Widiger, T. A. (1994). DSM-IV sourcebook. American Psychiatric Association eBooks.
636. Wilson, D. S., & Nutt, P. D. J. (2013). Insomnia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199674558.003.0003
637. Wilson, K. C., & Saukkonen, J. (2004). Acute Respiratory Failure from Abused Substances. Journal of Intensive Care Medicine. https://doi.org/10.1177/0885066604263918
638. Winkelman, J. W. (2009). The Diagnosis and Work-Up of Insomnia. CNS Spectrums. https://doi.org/10.1017/s1092852900003941
639. Wirz‐Justice, A. (1986). [Biological rhythms and depression].. PubMed.
640. Wirz‐Justice, A. (2003). Chronobiology and mood disorders. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2003.5.4/awirzjustice
641. Wise, E., Lyketsos, C. G., & Onyike, C. U. (2018). Aggression and Violence. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615371990.jl06
642. Wulandari, A., Kusuma, M. D., & Pancarani, R. (2023). Bipolar disorder - difficulties in managing emotional ups and down in an entertainer life: a case report. https://doi.org/10.35990/amhs.v1n3.p137-143
643. Wyatt, J. P., Illingworth, R. N., Graham, C. A., Hogg, K., Clancy, M., & Robertson, C. E. (2012). Environmental emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199589562.003.0006
644. Wölfling, K., Müller, K., Dreier, M., & Beutel, M. (2019). Verbesserung kognitiver Performance und psychischem Funktionsniveau nach verhaltenstherapeutischer Behandlung von Patienten mit Internetsucht. Suchttherapie. https://doi.org/10.1055/s-0039-1696221
645. Xiao, J., Chan, C. W., & Chow, K. M. (2019). LIVING WITH DIGNITY AMONG CHINESE CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A QUALITATIVE STUDY. https://doi.org/10.26226/morressier.5cdbe0ab618793e647b12cfb
646. Xie, C., Chen, P., & Liang, S. (2012). The Role of Blue Native/ SDS PAGE in Depression Research. InTech eBooks. https://doi.org/10.5772/33351
647. Yadav, N. (2005). TODAY’S ERA: THE HEALTH BEHAVIOR AND RISK FACTORS WITH DEPRESSION. World Journal of Advance Healthcare Research.
648. Yadav, S., & Srivastava, K. (2019). Body shape concerns and locus of control among young adults. International journal of research in social sciences.
649. Yamada, T., Inadomi, J. M., Bhattacharya, R., Dominitz, M. J. A., & Hwang, J. H. (2013). Approach to the Patient with Unexplained Weight Loss. https://doi.org/10.1002/9781118572610.ch4
650. Yee, B. J., Liu, P. Y., Phillips, C. L., & Grunstein, R. R. (2013). Neuroendocrine aspects of sleep apnea. CRC Press eBooks. https://doi.org/10.3109/9781420020885-16
651. Yuliana, Y., Arhami, M., & Hendrawaty, H. (2023). Sistem Pakar Diagnosa Tingkat Depresi pada Mahasiswa Menggunakan Metode Fuzzy Tsukamoto Berbasis Web. https://doi.org/10.30811/jtrik.v6i1.4705
652. Yum, S. W. (2024). What Are the Most Important Components of the Exam in Evaluating a Hypotonic Baby?. CRC Press eBooks. https://doi.org/10.1201/9781003523659-27
653. Zalpuri, I., Matzke, M., & Joshi, S. V. (2024). Obsessive-Compulsive Disorder in Children and Adolescents: Early Detection in Primary Care Settings. PEDIATRICS. https://doi.org/10.1542/peds.2024-069121
654. Zamorski, M. A., & Ward, R. (2000). Social Anxiety Disorder: Common, Disabling, and Treatable. The Journal of the American Board of Family Medicine. https://doi.org/10.3122/15572625-13-4-251
655. Zhu, X., Zhang, J., & Li, M. (2012). [Decreased sound tolerance and tinnitus].. PubMed.
656. Zhurkova, N. V., Volgina, S. Y., Gamirova, R., & Solovyeva, N. A. (2022). Early diagnostics of motor disorders in children: an interdisciplinary approach. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). https://doi.org/10.21508/1027-4065-2022-67-5-225-230
657. Zinich, L., Korpachev, V., & Hovaka, V. (2022). Дистрес при цукровому діабеті. Endokrynologia. https://doi.org/10.31793/1680-1466.2022.27-2.124
658. Zúñiga, R. L. (2017). Delirium y la presencia de respuesta inflamatoria sistémica, descontrol glucémico e hipoxia en pacientes mayores de 65 años en el servicio de urgencias médicas del Hospital General de Pachuca..
659. Šostar, Z., Vodanović, M., Breitenfeld, D., Breitenfeld, T., Buljan, D., & Granić, R. (2009). Composers - Substance Abusers. Alcoholism and psychiatry research Journal on psychiatric research and addictions.
660. Šumarac-Dumanović, M., Micić, D., Macut, Đ. P., Kendereški, A., Zorić, S., Cvijović, G., & Pejković, D. (2002). Hipoglikemijski sindromi - dijagnostički i terapijski pristup i prikaz dva slučaja. ABC - časopis urgentne medicine.
661. Žbulj, A. (2019). Psihičke poteškoće/poremećaji u razdoblju babinja.